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For the successful establishment of secondary tumours, blood-bome 
metastatic tumour cells must adhere and spread on the vascular endothelium before 
they can migrate through it to form secondary growths in the tissue beneath. In this 
study an in vitro assay was developed to study the behavourial interactions between 
B16F10 cells and Bovine aortic endothelial cells.
It was hypothesized that molecules synthesized by the endothelial cells may 
be involved in the mediation of the adhesion, spreading and migration events and 
hence that such molecules may possibly be involved in the process of haematogenic 
metastasis. Endothelial derived extracts were obtained from the cell surface and 
from conditioned medium. The extracts were tested for their adhesion promoting 
abilities in a quick dot blot adhesion assay. To verify that these molecules 
promoted adhesion, antibodies were raised against the extracts. Partial 
characterisation of the molecules was achieved using SDS-PAGE and 
immunoprobing. The extracts were also tested for their spreading and migration 
promoting properties. An attempt was made to block the adhesion, spreading and 
migration events using antibodies directed against components of the extracts. 
Clearly, if endothelial-derived molecules are involved in metastasis, then preventing 
the mediation of adhesion, spreading and migration may ulitimately have relevance 
in the clinical situation.
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I GENERAL INTRODUCTION
 m L i m m c . %
Tumour cells may tentatively be classified as either 
benign or malignant. The classification may be based on 
several factors, namely comparison with normal cells,
composition, morphology, growth and cell behaviour (Sherbert, 
1982). Growth and cell behaviour properties are common
indices used to allow a reliable distinction to be made
between the two types of tumour cells. For a more detailed 
account of the differences between benign and malignant
tumours see the following reviews: Cole, 1973; Weiss, 1976;
Sherbert, 1982; Vincent, 1985 and Weiss, 1985.
Briefly, benign tumours usually grow by expansion 
through cell division, remain localised and displace
surrounding tissue (Woodruff, 1980). Pressure atrophy to 
cells surrounding the tumour, may result in the formation of a 
fibrous coating, around the tumour. However, this is not a
universal feature of benign tumours (Sherbert, 1982). 
Notably, infiltration and destruction (invasion) of the tissue 
surrounding the tumour does not occur (Weiss, 1985).
Malignant tumours also grow by expansion through cell 
division and can displace surrounding tissue, but extensions 
from the tumours enable invasion to occur (Weiss, 1976). In 
addition malignant cells can also spread or metastasize to
other areas of the body (Cole, 1973; Willis, 1973). Therefore 
the best criteria for determining malignancy are invasion and
i. Invasion of the primary tumour into surrounding tissues.
ii. Spread of the tumour into body cavities and vessels and 
release of tumour cells for metastasis.
iii. Arrest of tumour cells at particular sites and invasion 
into surrounding tissue.
iv. Manipulation of the new environment to promote tumour 
cell survival, vascularisation and tumour growth.
metastasis (Vincent, 1985). A frequently cited exception to 
this general rule, is basal cell carcinoma. This common form s
of skin cancer, rarely, if ever, metastasizes, although it is 
capable of invading widely and may be highly destructive 
(Levenne .«giLai.. 1982) . The reason that this tumour displays 
such a marked distinction between invasive and metastatic 
characteristics is not known.
Metastasis may be defined as the transfer and spread of 
tumour cells from a primary site to one or more remote
secondary sites (Roth  al, 1976). A series of sequential
steps, leading to the formation of distant métastasés was 
proposed by Nicolson and Winklehake (1975):
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The first steps leading to metastasis are extension and 
local invasion (reviewed by Fidler and Nicolson, 1981). Local 
invasion is usually a fundamental step leading to spread of 
tumour. By breaching basement membranes (Trinkaus, 1976; 
Nicolson, 1981) (cellular sheet-like structures) (Siegal .e..t 
a,l, 1981) and interstitial connective tissues (consisting of
cells located in a matrix of collagen fibres, glycoproteins 
and proteoglycans) (Weiss, 1985), invasion of surrounding 
tissues can occur (Willis, 1973; Poste and Fidler, 1980).
The following observations, made .lo vltm, may help
account for the release mechanisms involved in invasion and ;| 
are reviewed by Hart (1981):
(1) an increase in amoeboid activity
(2) a decrease in adhesiveness
(3) loss of contact inhibition
(4) a possible release of lytic enzymes.
The relative importance of these mechanisms may vary 
from tumour system to tumour system (Cole, 1973). 
Susceptibility of host tissue to tumour cell invasion varies 
with the tissue type: cartilage, tendons, ligaments and
arteries are relatively resistant, whereas veins, lymphatics, 
soft tissue and muscles are easily invaded (Willis, 1973). It 
would appear that tissues rich in ground substance or those 
containing dense elastic or collagen fibres, provide a more
1
successful barrier to malignant cells (Weiss, 1985). Normal 
host interactions at the site of invasion may also be # 
important (Woodruff, 1980).
Once primary malignant cell invasion has occurred, the
next step appears to be cell detachment when single tumour
cells or tumour emboli, separate from the primary mass
(Sherbert, 1982). Release mechanisms (reviewed by Weiss, 
1985), include adhesive weakness, local cell rupture and 
enzymatic destruction, among others.
 SEBE.m._QE. XUMQ.URS.
There are three major pathways involved in tumour cell 
dissemination following local invasion, as outlined by Cole 
(1973) and Willis (1973):
This route is taken particularly by carcinoma (tumours 
arising from epithelial cells) (Lindberg, 1972; Carter, 1978)
and to a lesser extent by malignant melanoma (tumours arising 
from the melanin producing cells in the skin) (Carter, 1978;
1984). Primary tumours do not contain lymphatic vessels and 
so major points of entry are through small lymph vessels near
the edge of the growing lesion (Carr e.t al, 1981) . Access is
generally achieved through the structural features of these 
small vessels which lack a basement membrane and have a high 
proportion of gaps between the endothelial cells (Yoffey and
_ J:' - 1 '•■•j "j-.i - <
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Court ice, 1970) . As in the case of macrophages and | 
lymphocytes, tumour cells may enter the vessels through these 
gaps (Carr , 1976) and pass into the lymph nodes (Hewitt
and Blake, 1975) which are able to filter clumps of cells, but 
presumably not single cells (Cobb and Steer, 1987).
Tumour cells may also readily enter thin walled venules 
(Papadimitriou and Woods, 1975) and these cells may 
subsequently gain access to the lymphatic system via 
anastamoses between venules and small lymphatic vessels (Wood,
1958; Haagenson, 1972; del Regato, 1978). There is now 
substantial evidence that malignant cells can pass freely 
between the lymphatic and circulatory system (Fidler et al.
1978) and the belief that tumour spread occurs exclusively by 
one or other, is an oversimplification.
The most common route for metastasis is via the 
circulatory system. An example being melanoma (Carter, 1978).
There are three routes into the circulatory system as shown in 
Fig, 1, p8 (taken from Weiss, 1985): lymphatic entry, direct
venous invasion and invasion of tumour vessels.
This occurs if cell detachment from the primary tumour 
results prior to contact between tumour and blood vessel 
(Weiss, 1985). See Fig. 1(a).
I
Malignant cells may enter the bloodstream by invading 
blood vessels lying near the advancing edge of the tumour 
(Haagensen, 1972). See Fig. 1(b). It is thought that 
mechanical (Easty and Easty, 1978) and/or enzymatic factors, i
occurring at the edge of growing tumours (Kleinerman and 4 
Liotta, 1977), may contribute to penetration of the vascular 
system.
Vascularisation of the primary tumour, is thought to be
triggered off by tumour angiogenic factors (Folkman e.,fe Ml,
1971; Folkman, 1974). Invasion of these tumour vessels may 
occur through defects in vessel walls (Willis, 1973; Warren,
1974). These vessels are often imperfectly formed with 
irregular lamina, discontinuous or sometimes
abnormalendothelium and defective membranes which make them 
more penetrable (Carter, 1984). See Fig, 1(c).
 .S.p.r„e,.a.4..„.by .s..ur.f. .ft,c.e..
Tumour cells implant readily on the endothelial surface 
of pleura and peritoneum (Cole, 1973). When this occurs on an 
extensive scale, it is invariably associated with an effusion 
of fluid containing tumour cells (Woodruff, 1980). 
Dissemination of cancer of the lung in the pleural cavity and 
of cancer of the ovary, stomach and colon in the peritoneal 
cavity, are examples (Willis, 1973).
1
Tumour cells may also implant on epithelial surfaces
(Cole, 1973); this occurs in the urinary tract from papillary
carcinoma of the renal pelvis and in the bladder from primary
bladder tumours (Willis, 1973).
Spread also occurs in the gastointestinal tract (Cole,
1973), but appears to depend on a pre-existing breach in the j
continuity of the epithelium (Woodruff, 1980). Implantation M
of tumour cells in the subcutaneous tissue and in the wall of 
the colon may also occur during the course of surgical 
operations (Cole, 1973).
I
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Fig. 1 shows tumour cell spread by entry into the
circulatory system on the initial dissemination 
route.
(a) Detachment distant from the vein enables 
lymphatic entry to occur before direct venous 
entry.
(b) Detachment directly into a vein favours venous 
over lymphatic entry but does not exclude 
lymphatic entry from tumour margins.
(c) Cell shedding into tumour vessels via vascular 
clefts also favour venous over lymphatic entry but 
does not exclude the latter.
1.5 ARREST a n d  DISTRIBUTION OF  TUMOUR CELLS I.M BLOOD-BORNE
MIAS,TA.SI.S
In this study, we are primarily concerned with events 
which occur in the circulatory system. First let us consider 
the events which occur in blood-borne metastasis, following 
invasion and spread.
Some tumour cells are released from the primary mass, 
possibly by becoming transiently less adhesive (Vollmers and 
Birchmeier, 1983), or by hydrolase activity of necrotic tissue 
which is prevalent in large tumours (Weiss, 1977). or by shear 
forces in the blood stream (Glucksmann and Cherry, 1964). In 
order to form metastses, these released circulating tumour 
cells must become arrested at particular sites, such as in
capillary beds (Wood .e,t &1. 1966) . As shown in clinical and
experimental studies, the mere presence of circulating tumour 
cells does not constitute metastsis (S'alsbury, 1975: Fidler ,e,.t 
al, 1978).
The site of arrest on the endothelial lining of the blood 
vessels may be non-specific and determined by the size of the 
clumps of tumour cells released from the primary mass (Liotta 
1976) . Large clumps of cells can become mechanically 
impacted in vessels and the size and deformabi1ity of the 
tumour cells, the diameter and distensibility of the 
capillaries and the interaction of the tumour cells with each 
other and with circlating components to
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create multice1lular emboli are relevant in this context 
(Poste and Fidler. 1900).
However, the arrest of smaller aggregates and single 
cells cannot be accounted for by mechanical means alone. The 
experiments of Wood (1958; 1966), described the association of 
tumour cells with platelets, lymphocytes and thromboplastic 
components during the arrest process. Various workers have 
since shown that tumour cells do indeed undergo interactions 
with these host cells and components to form stable aggregates
(Pearlstien et .al. 1980; Fidler, 1978; Kohga and Tanaka,
1979). In addition, Stringfellow and Fitzpatrick (1979) and
Pearlstein ,e..t ,al (1980) suggest that prostaglandins may play a
role in the arrest of many tumours. Roos and Dingemans (1979) 
suugest that the inflammatory events involving fibrin 
deposition and platelet aggregation around the tumour cells 
may be activated to protect the cancer cells from blood shear 
forces rather than in playing an active role in the arrest of 
tumour cells. Some reviews on the role of inflammatory 
reactions in metastsis include those by Gatspar (1977);
Hilgard ,et a,.l (1977); Sherbert (1982). In brief, arrest and
emboli trigger events which couple an inflammatory response, 
blood coagulation and fibrinolysis, complement activation, and 
tissue damage, partially through products of the arachidonic 
acid cascade. The effects of vessel wall damage enhances 
further cancer arrest since exposure of the subendothelium 
results in platelets becoming adherent and activated.
Roos and Dingemans (1979), also suggest that more subtle
11
processes are required for arrest, especially in view of the 
fact that clinical and experimental observations show that 
certain tumours consistently metastasize to particular organs 
(organ-specificity) (Willis, 1973; Cole. 1973: Fidler and
Nicolson, 1976). More recently, emphasis has been placed on 
cell surface properties and an excellent demonstration of this 
was provided by Hart and Fidler (1980). They showed that 
B16F10 cells inoculated intravenously, form deposits on lung 
and ovary tissue even when these organs are transplanted to 
new locations within the body. This suggests that perhaps 
tumour cell surface determinants (Poste, 1980) or properties 
of the endothelial cells within different organs (Nicolson, 
1982; Auerbach and Joseph, 1984) contribute to arrest. 
Auerbach and Joseph (1984). postulated that capillary 
endothelial cells differ in their surface antigens, the 
differences reflecting their developmental history. These 
distinct organ-associated antigens on the cell surfaces could
explain organ-specif icity. A report by Dietrich  a..l (1983) .
suggested that heparan sulphates play a role in cell-cell 
recognition and adhesiveness since heparan sulphates are able 
to alter their configuration. To investigate organ-
specif icity, Alby and Auerbach (1984) used endothelial cells
from mouse brain or ovaries and tested them in an In v,l.tr.Q,
assay system for adhesion. They found that ovary-derived 
teratoma cells and a testicular teratoma with ovary seeding 
properties adhered preferentially to ovary endothelial cells. 
Whereas glioma cells adhered preferentially to brain
î
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endothelial cells. At present, too few endothelial cell lines 
are available to validate the studies. However, lymphocyte 
homing studies demonstrate clearly the importance of 
endothelial cell specificity in regulatin extravasation of 
circulating cells (Stamper and Woodruff, 1977; Chen and 
Singer, 1983; Streeter et al, 1988). Lymphocyte adherence to, 
and penetration through specialised endothelial cells, depends 
on the presence of specific adherence molecules on the 
endothelial cells (Butcher et al. 1979). Moreover, there is 
organ specificity in this lymphocyte-endothelial cell %
interactive system (Gallatin et a.1. 1983) .
Historically, two simple hypotheses have been used to 
account for organ specificity (reviewed by Weiss, 1985). The 
first, the "haemodynamic" or "mechanical" hypothesis, focuses 
on the delivery of tumour emboli to target organs. The 4
second, the "seed-soi1" hypothesis, focuses on the 
differential growth of arrested emboli in different target 
organs subsequent to delivery. A contribution to the theory 
of organ specificity was made by Fidler and Nicolson (1976), 
using B16F1 cells (tumour cells which show low arrest in the
lungs) and B16F10 cells (tumour cells which show high arrest
in the lungs). Following either tail vein or left ventricular 
injections of '^^IdU-labelled melanoma cells, the initial 
arrest of cells depended on the injection route; after
intravenous injection, more cells were arrested in the other 4 
organs than after intracardiac injections. However, 24 hours 
after injection, in both cell lines, more viable cancer cells
!.. j...-.-- 1: __ l.r . .....1 '..' i:... . . i -4^ ., . ! '-1, ... .... 4 A! . '
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were present in the lungs after intracardiac injections. 
Fourteen days after the injection, similar numbers of 
pulmonary tumours were seen following tail vein or 
intracardiac administration. The results suggested that the 
organ pattern of tumour colonisation was not determined by 
non-specific arrest in the first organ encountered by the 
injected cells.
At present, it appears that the "haemodynamic" hypothesis
Iaccounts for the majority of metastatic patterns of | 
development up to the stage of general arterial dissemination.
At the stage of general dissemination leading to end 
metastasis, some features of pattern are clearly not 
explicable solely in terms of the "haemodynamic" hypothesis.
This implicates the "seed-soi1" hypothesis. It seems likely 
that the "seed-soi1" hypothesis accounts for the differential 
growth rate of métastasés in different target organs, as 
distinct from the incidence of métastasés in these organs.
.I..Â E.aTABLI.SHMEH.T .QE MEXAETABEB
Ultrastructural studies indicate, that tumour cells gain 
a secure foothold in the circulatory system by adhering to
endothelial cells and to the underlying basement membrane
(Warren, 1974; Fidler eLai,. 1978: Auerbach and Joseph, 1984) .
It is the initial arrest reactions which culminate in the
adhesion of tumour cells to the vascular endothelium: this
leads to exposure of the sub-endothelium which also acts as an 
adhesion site. The tumour cells then exit (extravasate) from
14
the vessel into surrounding tissue(s) in order to escape from 
the hostile environment of the circulatory system. 
Extravasation of malignant cells is believed to involve 
mechanisms similar to those responsible for the initial 
invasion of blood vessels fPoste and Fidler, 1980). Following 
successful extravasation, small tumour cell lesions are 
f ormed.
Throughout the metastatic process, malignant cells are 
subject to attack by host defence systems which may be immune 
or non-immune (Weiss, 1985). The chances of métastasés 
developing from circulating tumour cells therefore are small 
(reviewed by Weiss, 1980) and may depend on:
(1) anatomical factors which influence the distribution of 
tumour embo1i;
(2) properties of the sites at which emboli are arrested and 
the extent to which they can satisfy the metabolic and 
other requirements of the particular tumour;
(3) properties of the tumour including its capacity to 
produce plasmin-like enzymes and
(4) various factors which influence local and general 
resistance to the tumour and modify the complex process 
of metastasis in ways which, for the most part, remain 
to be elucidated.
Even following extravasation, only a small proportion of 
tumour cells survive and are able to become established. 
Little is known about the factors involved in establishment 
and growth of métastasés in the target tissue. One factor may 
involve adaptation of the host tissue. For example, tumour
""I
■!
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cells are able to induce the^formation of blood vessels from 
the host circulatory system (Folkman and HaudenschiId, 1980) 
and are thought to be able to do this by releasing a tumour 
angiogenic factor(s) (TAF). This factor(s), which was
isolated by Folkman ,e,.t m.i (1971) , appears to be produced by
tumours both ln.,.,„ y i t m  and ia.,.viyo. (Klagsburn et aJL, 1976;
Phillips et .al, 1976; Brem ,et .a 1, 1977) .
The failure of the rest of the extravasated cancer cells 
to grow may be due to a number of reasons, including the 
inability of the tumour cells to overcome host defence
mechanisms (reviewed by Poste and Fidler, 1980; Weiss, 1985) 
and a non-favourable host environment (Folkman, 1975). Horak
e..t™ ,„al, (1986) showed that organs such as murine liver and
thyroid gland are able to rapidly and effectively diminish the
number of live tumour cells in vitro,, whereas murine lung and
ovary promote tumour cell attachment and survival. This
effect can also be exerted by cell-free organ conditioned 
medium and does not require previous contact with the tumour 
cells (Nicolson and Dulski, 1986). This observation
implicates a soluble substance in determining which organs 
allows the survival of different tumour types.
It would appear that the ultimately successful cells- as
few as 0.1% of the circulating tumour cells (Fidler  al.
1978) - would have to undergo rigorous selection in order to
survive (Roos and Dingemans, 1979; Poste and Fidler, 1980;;
Poste ,e.,t al, 1981). It is possible that only a small
subpopulation of cells in the heterogenous primary tumour
possess the characteristics to establish a successful
, ................................. , , ...... ,..............
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metastasis (Alexander, 1984; Fidler, 1978). Fidler (1973), 
showed that it is possible to obtain tumour lines with 
increasing metastatic potential by subjecting the cell
population to selection procedure involving successive s
transplantation with intermittent in vitro culturing. Fidler
injected viable B16 melanoma cells into the tail veins of 
C57BL/6 mice, isolated the tumour nodules which formed in the 
lungs of these animals and grew these isolated cells in tissue 'I
culture. The cells of the first l.n vivo selection for lung
colonization were designated B16F1. The B16F1 cells were 
injected back into syngeneic mice, and the pulmonary colonies 
that formed were isolated and adapted for culture (B16F2).
The procedure was carried out ten times to obtain the B16F10 
cell line. At each stage of the selection procedure, the 
ability of the cells to survive and form colonies in the lungs 
increased (Fidler and Nicolson, 1976; Fidler and Kripke,
1977). This outcome is compatible with the view that the 
original unselected primary tumour contained a number of 
variant lines differing widely in their potential for lung 
colonization.
The presence of heterogeneity within a primary tumour has 
profound implications for the way in which research should be 
carried out to identify the cellular properties responsible 
for metastasis. Experiments to identify features unique to 
metastatic subpopulations require comparisons to be made with 
non-metastatic (but tumourigenic) subpopulations of cells from 4
the same parent tumour. For this reason, the B16 melanoma and #
17
its variant cell lines are a good, model to work with.
From clinical studies. it is clear that the formation of 
metastses, is an important step in the pathogenesis of cancer, 
since metastatic growths are the cause of most deaths in
cancer patients (Nicolson et ai, 1976). A crucial step in the
survival of tumour cells which have been disseminated through 
the circulatory system is extravasation. A greater
understanding of this process may help in preventing the 
formation of métastasés.
Bearing this in mind, the aim of the work described in 
this thesis is to try and investigate in greater detail the 
interactions between tumour and endothelial cells, with a view 
to increasing knowledge on the process of extravasation.
■."i
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Extravasation, as defined by Wood (1958), is the process 
by which malignant cells adherent to endothelial cells 
penetrate the endothelial cell layer, bind to and finally 
invade the underlying basement membrane. In doing so the 
tumour cells escape host defence mechanisms (Weiss, 1985) and 
blood shear forces (Glucksmann and Cherry, 1964). This 
definition was arrived at from micro-cinematography
observations made by Wood (1958) of cancer cells crawling out 
from blood vessels in rabbit ear chamber experiments. In 
these experiments, Wood injected V2 carcinoma cells into the 
central artery of a rabbit ear, proximal to a transparent 
window implanted in the ear. The events following this 
injection were photographed at high magnification.
"Successful" tumour emboli were noted to form aggregates 
readily and to adhere strongly to the endothelium in 
comparison with "unsuccessful" tumour emboli. Adhesion to the 
endothelium was followed by formation of thrombi around the 
cells. Within a variable period from a few minutes to a few 
hours, the endothelial cells underlying the tumour thrombus 
appeared to become damaged. Leucocyte migration occurred 
beneath the tumour thrombus and the cancer cells followed,
passing through breaches in the endothelial lining caused by a 
variety of factors, including platelets, histamines and
leucocyte-mediated injury (Weiss, 1985).
Several mechanisms have been put forward to explain how 
tumour cells may leave the blood vessels:
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1. Escape of tumour cells through defects in the 
endothelial wall (Sherbert 1982; Carter, 1984).
2. Endothelial penetration by breakage of endothelial
intercellular junctions (Locker , 1970; Nicolson,
1981).
3. Proteolytic enzyme destruction of endothelial cells by
tumour cells (Liotta et al. 1980; Crissman, 1985). The 
enzymes are released from the pseudopodia of the tumour 
cells.
4. Penetration of endothelial cell cytoplasm by tumour cell
pseudopodia and by pinocytosis (Dingemans, 1974).
5. Endothelial wall rupture due to physical disruption as a
result of proliferation of tumour cells at the site of 
arrest by pressure of the growing mass (Basserga and 
Saffioti, 1955; Chew 1976).
6. Changes in permeability of the endothelium e.g. during 
inflammation, histamine release makes the endothelium
1 eaky (Majno , 1969; Ozaki ei-jSl, 1971).
Whatever the method of escape, the basement membrane is 
the major barrier to extravasation and it is likely that more 
than one mechanism is utilised in this process (Crissman, 
1985).
A survey of the published literature of ln.....KiKQ studies, 
reveals the use of many different biological systems in the
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investigation of the interaction between tumour and
endothelial cells. Workers using in. Klfcro. systems have added
a further complication to the subject by confronting tumour 
cells of one species with endothelial cells of another 
species. The reasons for doing so are usually technical; but 
surprisingly, there is little evidence to show that the 
results obtained from studies of interactions between cells of 
different species and those obtained from systems utilising 
syngeneic tissues are markedly different (Easty and Easty, 
1984) . There are obvious differences between and in
Ki.Èr.Q studies. In.... KiKQ. there is a complex interplay of
hormonal, inflammatory and possibly immunological responses 
(reviewed by Eccles and Alexander, 1974; Sherbert, 1982;
Weiss, 1985; Hanna, 1985; Robins, 1986) which may contribute 
to the magnitude and rates of interactions; ln......ici.tr.Q these are
usually absent. Thus, systems would appear to be the
more desirable. In practice, the complexity and
interdependence of reactions, and the difficulty of
examining the effects of a single component, renders analysis
of la, ,irJ.KO. systems very difficult, while the relative
simplicity of the la._._Kl,±r.o systems facilitates analysis of 
mechanisms, but may yield data which are not substantiated by
subsequent experiments in animals. Nevertheless, In yitro
experiments have proven invaluable in elucidating endothelial 
and tumour cell interactions.
An elegant demonstration of interactions between two 
cell types (Kramer and Nicolson, 1979) involved a variety of 
tumour cells, fibroblasts, macrophages, lymphocytes and
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leucocytes seeded onto monolayers of bovine aortic endothelial
cells (BAE) . BAE cells are commonly used In vXtXlQ
experiments, because these cells form intercellular junctions 
and an extracellular matrix in culture of similar composition
to the basement membrane in K.iv..Q (Birdwell .e..t .ai ^ 1978).
Using time-lapse photography, Kramer and Nicolson (1979) 
observed that, in general, the malignant cells, monocytes and 
leucocytes, which can all invade the endothelium in..._.vi.K.o (Ward 
..«1, 1979), firstly adhered to the endothelial cells. This 
was followed by the retraction of the endothelial cells at the 
site of adhesion. However, only cells adjacent to endothelial 
cell junctions were able to migrate between the undersurface 
of the endiothelial and their extracellular matrices. The 
endothelial juctions then re-sealed, walling off the invading 
cells. Similar results were obtained by Zamora .e.La.1. (1980), 
who inoculated monolayers of endothelial cells grown on 
collagen gels with multice1lular spheroids of mouse mammary 
carcinoma. Again, retraction of the endothelial cells in the 
vicinity of tumour cells was observed following adhesion, and 
the mammary tumour cells spread on the collagen, migrating 
under and over the endothelial cells and into the collagen. 
The steps seen in these experiments correspond well with the 
observations made in the i.o,,„..Yi.zo. situation (Wood, 1958; 1966; 
Crissman, 1985).
The aim of this part of the thesis was to visualise 
behavoural interactions between tumour and endothelial cells.
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Due to some of the difficulties arising from studying this 
type of interaction , an model system was
developed. B16F10 cells were used for a variety of reasons in 
addition to their availability;
1. The cells can be easily distinguished by their 
morphology and colour (Kramer and Nicolson, 1979).
2. Comparison can be made with variants of the parent cell. 
These include cells with differing metastatic potential 
and métastasés arising in a variety of organs, for 
example brain and ovary (Brunson and Nicolson, 1978;
1979) and liver (Tao 1979) .
3. The cells are easily grown in culture as well as invivo 
(Fidler and Nicolson, 1981).
Initially, B16F10 cells were seeded onto BAE monolayers 
as described by Kramer and Nicolson (1979) and observations 
were made using light microscopy. This differed from the 
Kramer and Nicolson experiments, in that time-lapse 
photography was not used. The B16F10 cells adhered to the 
monolayer within 30 mins and tumour cells near endothelial 
cell junctions destroyed the monolayer in the regions proximal 
to the tumour cells after 24h. The retraction and re-sealing 
of the endothelium, described by other workers, could not be 
identified, possibly since time-lapse photography and/or 
magnification higher than x600 were not used.
One major disadvantage with the in.. .Kltr..Q assays
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previously described (Kramer and Nicolson,. 1979; Zamora ,e.fe. a.l,
1980) is that the tumour cells are seeded on top of 
endothelial monolayers. This limits the number of
observations which can be made, without making transverse
sections of the experimental material and thus introducing 
artefacts and misinterpretations into the system. Therefore 
the model system developed in this investigation allowed the 
study of interactions between the two cell types in a small 
volume, 10mm apart, onto different areas of a petri dish until
the cells had attached (typically 30 min) . Unattached cells
were aspirated off and the petri dish covered with medium. 
Observations of interactions between the two cell types as 
they grew towards each other were made under light and 
scanning electron microscopy. One problem associated with 
light microscopy is that identification of specific cells can 
sometimes prove to be difficult. In order to overcome this 
difficulty and to distinguish between the two cell types, 
cell-specific antibodies were used to stain the cells.
This model has some modifications from those previously 
described. It offers the potential of studying a wide range 
of tumour-endothelial cell interactions, including invasion, 
extravasation and angiogenesis. In addition, more detailed 
observations could be made regarding the interactions between 
tumour and endothelial cells than have been possible in the 
past.
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2,...2„.mTERI.ALS......AN.D....,METHODS.
B16F10 cells, supplied by Dr IJ Fidler (Frederick Cancer 
Research Centre, Frederick, MD, USA), were maintained in 
Eagle's minimum essential medium with Earle's salts and 
supplemented with benzyl penicillin (SOIU/lOOml), streptomycin 
sulphate (SOug/lOOml), glutamine (2mM), sodium pyruvate (ImM), 
essential vitamins, amino acids, and 10% heat inactivated 
fetal calf serum (FCS) (all from Gibco). This medium will be 
referred to as Eagle's complete (EC). Cells were subcultured 
every third day by the transfer of 2x10” cells per 9cm petri 
dish (Nunclon) after harvesting with 2mM EDTA in Dulbecco's 
calcium and magnesium-free phosphate buffered saline (CMF- 
PBS) . (See Appendix 1) . The cells were counted using a 
Coulter Counter Model ZB in conjunction with a Channelyzer 
CIOOO.
BAE cells, a gift from Dr JR Starkey, Montana State 
University, were also maintained in EC, but with the addition 
of insulin (0.013IU/ml) and endothelial growth factor (5ng/ml) 
(both from Sigma). Cells harvested after incubation for 3min 
at 37® C with 2mM EDTA and 0.1% trypsin in CMF-PBS, were 
subcultured every third day by the transfer of 6x10” cells per 
9cm petri dish.
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The amount of protein in solution was measured using a 
modification of the Lowry method (Larson ,e,.t..„...,al, 1986) ;
2m 1 stock reagent (1% CuS04, 10% 2M NaaCOs, 1% ION NaOH,
16.25% tartaric acid (D+) in distilled water) were mixed with 
0.1ml protein sample and 0.2ml of a 50% dilution of Folin 
Ciocalteau reagent in plastic micro cuvettes and left to 
incubate for 3min. To complete the reaction in lOmin, 0.2ml 
20mM ascorbic acid was added at room temperature and mixed 
well. After lOmin, reading at 660nm were taken in a Unicam 
SP1800 spectrophotometer and compared against a standard curve 
established using BSA ranging from 0.2mg/ml-2mg/ml.
Discs, 1cm in diameter, cut from surfactant-free 
nitrocellulose sheets (Millipore HATF 13750, pore size 
0.45um), were fitted into the wells of a Nunc 24-well tissue 
culture grade plate. A confluent 9cm plate of BAE or B16F10 
cells was harvested as described previously and resuspended in 
1ml PBS (see Appendix 1). Samples of cell suspension (2ul) 
were dotted around the circumference of each disc. To each 
culture well was added 1ml of 10% Marvel (dried milk protein) 
(w/v) in PBS/0.05% Tween 20 (v/v) for 30min at 37®C and the 
plates incubated to block other available protein binding 
sites on the nitrocellulose. The discs were then incubated 
with 1ml of primary antibody diluted in PBS (2ug/ml-200ug/ml)
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for 30min at 37-^ C. The discs were washed twice with PBS/Tween 
and then once with PBS, prior to a 30min incubation with 1ml 
of the appropriate phosphatase conjugated second antibody 
(Sigma) diluted 1:1000 with PBS at 37*C.
The discs were washed 3x with PBS and developed for 
20min with Fast violet B salt (Img/ml) and beta-naphthyl 
phosphate (Img/ml) diluted in sodium borate buffer pH8.7. 
(See Appendix 1). The discs were then rinsed several times in 
distilled water and left overnight in 1ml water to reduce 
background staining. The discs were dried at room temperature 
on tissue paper. In order to score the intensity of the
colour of the discs, it was necessary to include positive 
controls and negative controls. The positive controls 
consisted of dotting the phosphatase conjugated second 
antibody onto a nitrocellulose disc, followed by blocking and 
developing. The negative control consisted of dotting the
test protein solution onto a nitrocellulose disc, followed by 
blocking, incubation with phosphatase conjugated antibody and 
developing.
A confluent 9cm plate of BAE or B16F10 cells was 
harvested as usual and resuspended in EC medium. The cells 
were seeded at their usual density (see Part 2.2.1) in 96-well 
plates and grown to confluency. The first row was used as a 
blank and no cells were grown in these wells.
' The cells were fixed for 20mins at room temperature with
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50ul of 3% glutaraldehyde in PBS/well. Excess fixative was 
discarded and the plate washed twice with PBS/Tween 
(200ul/well) before incubating with lOOul/well of diluted 
primary antibody for 60mins at 37®C. The plate was washed 
twice with PBS/Tween before incubating with 50ul of 
phosphatase conjugated second antibody as outlined above (Part 
2.2.3a) for 2h at 37®C. The plate was washed twice with 
PBS/Tween and 50ul of p-nitrophenyl phosphate substrate 
(Sigma) (Img/ml in O.IM glycine buffer pHlO.4, O.OOIM MgCla 
and O.OOIM ZnCla) was added. The colour was allowed to 
develop for 30min. The developed solution was transferred to 
a new 96-well plate before reading on an ELISA plate reader. 
An O.D. three times higher than background was taken as 
positive.
2 .2.4 Polyclonal antibody production
A 1ml suspension of BAE or B16F10 cells (scraped from 
five 9cm plates) in PBS or 1ml protein (lOOug/ml) in PBS was 
vortexed with 1ml FCA added dropwise. The mixture was 
injected into a New Zealand white rabbit, at 10 subcutaneous 
injection sites on its back (0.2ml/site). Six weeks later a 
small sample of the serum obtained from an ear bleed was 
assayed in an ELISA system to check antibody specificity. The 
rabbit was reboosted with the same protein in FIA and left for 
3 weeks before bleeding from the ear (30ml) . Serum was 
obtained by allowing the blood to stand for Ih at 37®C, 
followed by incubation at 4®C overnight. The mixture was then
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centrifuged for lOmin at 680g. The supernatant obtained 
(serum) was then purified as described below. If the activity 
of the antibody appeared to be decreasing the reboosting step 
was repeated.
Saturated ammonium sulphate solution (pH7.0) was added 
dropwise to antibody containing serum at 4®C and the mixture 
stirred continuously until 40% saturation was achieved. The 
mixture was stirred for a further 30min before being 
centrifuged at 680g for lOmin. The pellet was dissolved in 
10ml of PBS and dialysed overnight against PBS. In the 
meantime, Ig of Protein A-sepharose CL-4B (Pharmacia) 
resuspended in 4m1 PBS was poured into a plugged 10ml syringe. 
The column was equilibrated with 10ml O.IM glycine-HCl buffer 
PH3.0 (eluting buffer) followed by 10ml PBS pH7.4. The 
antibody solution was then mixed with the immobilized proteinA 
by shaking and the protein A allowed to settle by gravitation 
for 15min. Unbound material was washed off with 10ml PBS, and 
bound material was eluted with 10ml of the eluting buffer. 
This solution of IgG was neutralised with l.OM Tris-HCl pH8.0. 
The protein content was assayed (see Part 2.2.2) and the O.D. 
at ■ 280nm read (the expected O.D. is 1.4 for IgG of 
concentration Img/ml). The solution was filtered and stored 
frozen in 1ml aliquots.
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Confluent cells were fixed with 3% glutaraldehyde for
20min at 37®C. The fixative was washed off with PBS, before
adding the first antibody, diluted 1:100 in PBS, for 30min at 
37® C.
The cells were washed gently with PBS before incubating 
with phosphatase-conjugated second antibody for 2h at 37®C.
The cells were then washed once and the colour developed as
described in Part 2.2.3a.
B16F10 and BAE cells were harvested as usual and 
resuspended in EC medium with BAE supplements (see Part
2.2.1). The B16F10 cells were seeded in 2 areas (in 10-20ul 
of medium) on one side of 5cm petri dishes at 1x10* cells and 
BAE cells at 2.8x10* cells in 2 areas on the other side of the 
petri dishes keeping the four seeding areas about 10mm apart. 
The petri dishes were left at room temperature for 30min until 
the cells had attached to the plastic. The dots were 
aspirated and fresh medium gently placed into the dish. The 
medium was changed at three day intervals. Observations were 
made using a light microscope. In order to obtain some
indication as to the viability of the cells, a trypan blue dye 
exclusion test was carried out. This involved placing 5ml of 
0.1% trypan blue solution into the tested petri dish. After
Imin the dye was aspirated and 5ml of PBS added to the dish.
If the cells stained dark blue they were not viable. In some
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cases the plates were stained with antibody as outlined in 
Part 2.2.6. Scanning electron microscope observations were 
made on some plates as outlined in Part 2.2.8.
The cells were grown as described in Part 2.2.7. The 
cells were fixed with 3% glutaraldehyde in PBS, for 30min at 
room temperature. Discs were cut from the petri dish using a 
heated cork borer. The samples were sequentially dehydrated 
in 50% ethanol (15min), 70% ethanol (15min), 96% ethanol
(15min) and 100% ethanol (15min, 2 changes). The discs were 
then critical point dried and gold sprayed by Mr. I. Davidson, 
Department of Biology and Preclinical Medicine, St. Andrews. 
The scanner used was a JSM-35CF, and the photographic film 120 
FPA. The photographs taken were examples of interactions 
occurring between the two cell types.
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2......a.....HES.ULIS
In this study an model was developed in order
to visualise interactions between B16P10 and BAE cells. Both 
cell types were seeded in the same petri dish and interactions 
were observed using light and scanning electron microscopy. 
Under the scanning electron microscope, specific cells were 
distinguished by their morphology and size, but under the 
light microscope this was not as easy to do. This problem was 
overcome by raising cell-specific polyclonal antibodies to be 
used to immunostain the two cell types.
One problem encountered was a result of the endogenous 
enzyme activity of the cells which resulted in false positives 
in the antibody specificity tests (Goding, 1986). For 
example, the BAE cells reacted with the alkaline phosphatase 
substrate (B-naphthyl phosphate and Fast violet B salt) used 
in developing the colour reaction of the antibody staining. 
(See Part 2.2.3a). This was attributed to alkaline 
phosphatase activity of the BAE cells. In order to try and 
remedy this problem, peroxidase conjugated second antibodies 
and ■’ the appropriate substrate (o-phenylenediamine - see 
Appendix 1) were tried. In this case the B16F10 always 
stained positive. This was attributed to the endogenous 
peroxidase activity of the B16F10 cells. This activity could 
be blocked using hydrogen peroxide and methanol (Farr and
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NAkane, 1981). However, due to the dénaturation of the 
antigens on the cells by these chemicals, the primary 
antibodies then did not interact with the cells. It was 
eventually decided to use antibodies raised against B16F10 
cells (a-FlO - 9.2mg/ml), with alkaline phosphatase conjugated 
second antibodies. This combination gave a slightly stronger 
staining for the B16F10 cells than the background staining for 
BAE cells and so it was possible to distinguish between the 
tumour and endothelial cells (See Photographs 1 and 2).
Observations were made daily. The first changes were
noted 3 days after seeding and then at intervals as indicated 
below. The following results are representative of ten dishes 
for each day and a total of four repeat experiments. The
observations made were highly reproducible and typically 80- 
90% of the dishes showed the interactions described.
On the third day of growth the B16F10 cells appeared as 
two discrete compact clusters. (See Fig. 4). In the centre 
of the clusters (which had doubled in size from the initial 
seeding) the cell density was very high and the cells were
rounded and overgrown into thick aggregates (See Photograph 
1) . On the outer edge of each cluster the cells grew
outwards. The cells on the outer edge varied in morphology - 
a few were spread with flattened pseudopodia, but the majority
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were elongated and lined sideways on (See Photograph 1 and 
Scanning electron micrograph 1) . A few of the aggregated
cells from the centre had detached and become attached 
elsewhere in the petri dishes and a few single cells appeared 
to have "escaped" from the discrete dots; so colonied 
developed in the initially bare area of the petri dishes.
On the other hand, the BAE cells were not as compact as 
the B16F10 cells. The centre of each cluster of BAE cells had 
a typical cobblestone appearance, but at the outer edge, the 
cells were loosely arranged, with the cells having large 
widespread lamellipodia (See Photograph 2 and Scanning 
electron micrographs 2 and 3) . In the area of the petri dish 
between the tumour and endothelial cells there were large 
numbers of single endothelial cells. However there were no 
areas of interaction between the tumour and endothelial cells.
Photograph 1 shows the leading edge of the B16F10 
cells in the confrontation assays after three days 
growth. Towards the top of the photograph dense 
aggregated cells can be seen. Magnification x240.
Scanning electron micrograph 1 shows the leading 
edge of the B16F10 cells in the confrontation assays 
after three days growth. Magnification xl560.
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Photograph 2 shows the edge of the BAE cells after 
three days growth. The top of the picture shows 
that the cells are more tightly spaced than at the 
edge. Magnification x270.

Scanning electron micrograph 2 shows the BAE 
monolayer. Towards the top right hand corner the 
cells are confluent. But at the leading edge the 
cells are loosely arranged. Magnification xl72.
Scanning electron micrograph 3 shows the BAE cells 
at the leading edge in greater detail.
Magnification xl320.
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On the tenth day of growth, the B16F10 cells still 
appeared as discrete clusters (doubled in diameter, compared 
with day 3) . (See Fig 4) . However, the centres contained 
very dark aggregated cells (see Photograph 3 and Scanning 
electron micrograph 4). The outside edge was still compact. 
Only one half of the dishes was covered with tumour colonies 
and this area appeared to be in the area nearest to ’ the 
original tumour cell seeding areas. (See Fig 4).
By this time single BAE cells started to appear at the 
leading edge of the tumour cells. The morphology of the BAE 
cells appeared to change and it seemed as though the BAE cells 
were lying across the path of the B16F10 cells. (See Scanning 
electron micrograph 5).
Within the BAE monolayer, there were areas where the 
aggregated tumour cells from the centre of the tumour cell 
dots had landed after detachment. This could be equeated to
the ,in. J/TIk q situation where tumour cells detach from the
primary tumour mass in the circulatory system and become 
arrested on the endothelium. The BAE monolayer, proximal to 
the tumour aggregate, appeared to become compressed and to be 
evenly pushed away from the aggregates. Results from scanning 
electron microscopy showed that the BAE cells were lifted off 
the base of the dish and rolled up as the tumour cells invaded 
underneath. The tumour cells began to spread and proliferate 
on the revealed plastic. At higher magnification it could be 
seen that the B16F10 cells had started to migrate under this 
compressed area. (See Photograph 4).
Photograph 3 shows a dense aggregate (A) of B16F10 
cells which is able to detach and float to 
other areas of the petri dish. (After ten days 
growth). Magnification x240.
Scanning electron micrograph 4 shows in greater 
detail B16F10 aggregates (A) after ten days growth. 
Magnification xl592.
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Scanning electron micrograph 5 shows the BAE cells 
(E) lying in the path of the B16F10 cells (T) after 
ten days growth. Magnification x640.

Photograph 4 shows the compression of BAE cells (E) 
after ten days growth. Magnification x240.
Fig 2 shows diagramatically the interaction between 
the endothelial cells (E) and the B16F10 cells (T) 
after ten days growth.
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Photograph 5 shows the BAE monolayer (H) being 
pushed back after seventeen days growth. Note that 
the B16F10 cells (T) have begun to aggregate (A) in 
the centre of the retraction area. Magnification 
xl60.
Scanning electron micrograph 6 shows the BAE 
monolayer (E) rolled up after seventeen days growth, 
it also shows the B16F10 cells (T) moving underneath 
the monolayer. Magnification x440.
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Photograph 6 and Scanning electron micrograph 7 show 
the rolled up monolayer of BAE cells (E) at a higher 
magnification and the B16F10 cells (T) moving 
underneath the monolayer. Magnification x270 and 
xl720 respectively.
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Photograph 7 shows an aggregate of B16F10 cells (A) 
on the BAE monolayer (E). The monolayer has started 
to develop vacuoles, but the cells are still viable 
as revealed by a trypan blue dye exclusion test. 
Magnification xl60.
Photograph 8 shows the B16F10 aggregate in higher 
magnification. However, the nature of the 
interaction between the aggregate and the monolayer 
is not revealed. Magnification x280.
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By day 30 of growth, the whole dish was covered with 
cells (see Fig. 4) and the whole endothelial cell layer 
appeared compressed. As the B16F10 cells began to move under 
the BAE monolayer they became elongated and began to palisade. 
(See Photograph 9) . Once they had moved under the monolayer 
they regained a spread morphology which could be observed 
through gaps in the monolayer. (See Photographs 10 and 11) . 
Some of the BAE cells became so compressed, they appeared to 
be fused into aggregates. However, by trypan blue dye 
exclusion test, some of these cells were still viable but at 
the edge and 0,015mm into the compression, the cells were non- 
viable.
After this time the experiment was stopped as no other 
changes were seen to take place after this time.
Photograph 9 shows the interaction between the two 
cell types after thirty days growth. Note that the 
B16F10 cells are exhibiting a palisading effect. 
Magnification xl70.
Fig 3 shows diagramatically the zone of non-viable 
cells.
0.015mm
isading B16 cells 
BAE cells
compressed 
BAE cells
zone of dead 
BAE cells
IPhotograph 10 shows the interaction between the two 
cell types after thirty days of growth. It can be 
seen that the B16F10 cells under the endothelial 
cells are taking on a spread morphology. 
Magnification x280.
Photograph 11 shows at a higher magnification the 
spread B16F10 cells underneath the BAE cells. 
Magnification x600.
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Fig 4 shows a diagram of the areas covered by B16F10 
and BAE cells on a typical stained petri dish at the 
stated time periods. Not drawn to scale.
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The model system developed in this study showed two 
types of confrontation between tumour and endothelial cells. 
The first type which resembled invasion, occurred between 
substratum-attached tumour cells and the endothelial 
monolayer. The second type, which resembled extravasation, 
occurred between aggregated tumour cells and the endothelial 
mono1ayer.
This type of interaction occurred as the two cell types 
grew towards each other in a process similar to invasion of 
the endothelium. It appeared as though initially, the two 
cell types adhered to each other, followed by the B16F10 cells 
inserting pseudopodia under the BAE cells.
This interaction involved B16F10 cell aggregates and the 
endothelial cells. It would appear that at high densities the 
B16F10 cells become detached from the substrate and attached 
to each other (as aggregates). Initially these aggregates 
still adhered by one or two cells to the plastic and a trypan 
blue dye exclusion test revealed that these aggregated cells 
were viable. Following aggregation, the cells were able to 
detach from the substrate (although they were still 
aggregated) and to adhere either to other cell-free sites on
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the plastic or onto the BAE monolayer. This is similar to the
in. v.i.KQ. situation when clumps of cells become detached from
the primary tumour and circulate in the vascular system 
(Sherbert, 1982). The aggregated cells adhered strongly, 
adjacent to endothelial intercellular junctions, and in these 
areas the BAE cells were seen to peel back. This may be 
compared with the events which occur in......y.i.KQ, prior to and
during extravasation (Wood, 1968, Crissman, 1985). At this 
time changes observed in behaviour of substratum-attached and 
aggregated tumour cells were identical.
In both types of interaction it was observed that the 
tumour cells adhered to the edges of the BAE cells. These 
observations indicate the importance of the endothelium in the 
initial step of causing arrest of the tumour cells. It would 
seem from these experiments, that the presence of
leucocytes and platelets are not necessary for interactions to 
occur between the tumour and endothelial cells. This is also 
the view held by Warren (1976). Following adhesion, the 
tumour cells penetrated the endothelium, not by piercing the
cells (as described by Chew et al. 1976), not through defects
in the surface of the endothelium (Carter, 1984), but by 
breaking intercellular junctions (as described by Nicolson, 
1981). This was followed by the BAE cells being rolled away 
from the tumour cells. The tumour cells then appeared to 
spread and move on the extrace 1 lular matrix which had been 
laid by the endothelial cells (Kramer , 1982).
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The results obtained in this study corresponded well 
with those of other workers (Kramer and Nicolson, 1979; Zamora
et ai, 1980). The difference between the observations made in
this study and ' those of the other workers was that the 
retraction and re-sealing of the endothelial cells over the 
tumour cells, could not be identified. It may be possible 
that the re-sealing of the endothelium is a very transient 
process, followed closely by damage of the endothelium. If 
the processes follow one another closely the advantage of 
using time-lapse photography becomes apparent. In this study 
I observed that within 24 hours of tumour cell attachment, the 
BAE monolayer, proximal to tumour cell adhesion, was non- 
viable as determined by trypan blue staining. In the Kramer 
and Nicolson studies the experiments were stopped before this 
time, therefore damage was not mentioned. It is possible for 
B16P10 cells to damage the integrity of the endothelium by 
production of degradative enzymes. These include plasminogen 
activators and collagenase IV (Liotta .e±.„.....ai., 1980; Kramer and 
Nicolson, 1982; Reich 1988) . The conclusion I draw
from my observations is that once the endothelial cells become 
detached from the substrate by the action of tumour cells, re­
attachment by the endothelial cells to form a contiguous
structure is not observed lo. Kltro (Young and Herman, 1985) .
If it does, it cannot do so for long. On the other hand, it 
is possible for re-sealing to occur , since repair
mechanisms rapidly follow tissue injury (Sporn and Roberts, 
1986).
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It is also interesting to compare some of the 
observations made in this study with the description of in 
vJ-KQ. extravasation of B16a (amelanotic) cells in C57 mice 
(Crissman, 1985), in which endothelial cells were gradually 
displaced by contact of tumour cells with the vascular 
basement membrane. The mechanism of endothelial cell 
displacment by tumour cells could not be identified, but 
appeared to occur at inter-endothelial cell junctions with 
gradual retraction of the endothelial cells as the B16a cells 
increased their area of basal lamina contact. Ther was no 
evidence of active migration by B16a cells. Extravasation 
occurred through a combination of inravascular tumour cell 
proliferation and destruction of the vascular basement 
membrane by the B16a cells. Hence observations made in this 
thesis may well illustrate some of the mechanisms by which 
B16a cells extravasate
There are some limitations to the model which must be 
considered. The tumour cells used were murine and the 
endothelial cells bovine, but as stated earlier, experiments 
using different species show little difference from those 
using syngeneic tissues (Easty and Easty, 1984). Also, it is 
likely that the interactions between B16F10 and BAE cells will 
follow general principles and will not be affected by species 
source of the cells. For future experiments, it will be 
important to see the response of other variant cells of the 
B16 melanoma and other tumour cell types, with these and other 
endothelial cell types to determine whether the observations
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made follow a general trend or are specific to B16F10 and BAE 
cells only. I have already carried out some preliminary
experiments using B16BL6 and B16F1 cells in confrontation with 
BAE cells. These experiments have yielded similar results as 
those obtained for B16F10. This suggests that the
interactions between B16 tumour cell lines and BAE cells are 
representative of a general trend.
The model used in this study has allowed a unique
observation of the interaction which occur between B16F10 and 
BAE cells and shows potential for further studies. 
Behavioural interactions between B16F10 and BAE cells have 
been illustrated which are not disimilar from those of initial 
vascular invasion and extravasation. It must be realised that 
a simplified model system such as this do not include the 
complex haemodynamical, mechanical and electrostatic
interactions which occur in. KXV.Q. between tumour and
endothelial cells. However, models such as these may provide 
some insight to the possible processes which occur in the in. 
kriza metastatic cascade and perhaps eventually even to the way 
these processes are controlled. This system also enables
addition of various factors such as platelets, histamine and 
prostaglandins to look at the effect that these components 
have on the interactions between tumour and endothelial cells.
Having obtained an overall view of extravasation, I 
thought it would be pertinent to study the processes
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occurring, in greater detail. The first question to be 
addressed was whether the composition of the cancer cell or 
endothelial cell surface affects tumour arrest. From the 
results of this chapter, it would appear that the endothelium 
might prove to be a fruitful source of molecules which promote 
tumour cell adhesion and spreading.
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 INTRODUCTION
The first barrier to cells which are disseminated 
through the vascular system, is the endothelial lining of 
capillaries (Nicolson, 1981). Tumour cells are seen to adhere 
to the endothelium before passing through it (Kramer, 1980; 
Kramer e..t al, 1982) .
Several theories have been put forward to account for 
cell adhesion phenomena. Initial considerations that cellular 
adhesion resulted from non-specific interactions via 
neutralisation of negative charge on cell surfaces or van der 
Waal's forces acting over broad areas of surface membrane 
(Curtis, 1973), have now been replaced with models featuring 
the interaction of several classes of cell surface 
macromolecules such as lectins (Raz and Lotan, 1981) and
glycoproteins (Terranova e..t al, 1983) with complementary
binding sites. It is known that the cell surface is crucial 
in all cell adhesion processes and studies with animal tumour 
models have indicated its important role in metastasis as well 
(reviewed by Nicolson, 1984). Endothelial cells are thought 
to play a major role in extravasation because they synthesize 
several proteins that have been implicated in cell adhesion 
(Jaffe 1976; Jaffe and Mosher, 1978; Sage , 1981).
From the results of the previous chapter it would appear that 
tumour cells adhere to the endothelial cells. Therefore 
molecule(s) from the endothelial cells seemed the best 
candidate(s) for promoting adhesion. Thus it was decided to 
study the adhesion-promoting properties of molecules extracted
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from endothelial cell monolayers. The most studied cell 
adhesion promoting factors relevant to this study which are 
thought to be involved in metastasis include fibronectin (Fn), 
laminin (Lm) and vitronectin (Vn).
A vast literature has developed on the subject of 
fibronectin over the past fourteen years. Fibronectins, 
comprise a class of closely related glycoproteins of) . They 
are found in two forms : a soluble plasma, amniotic and
cerebrospinal fluid protein and an insoluble protein in most 
basement membranes, on the surface of some cells and in soft 
connective tissue matrices (Yamada and Olden, 1978). Major 
producers of fibronectin are, fibroblasts, myoblasts and 
endothelial cells, but other cells produce lesser amounts. 
Some cells secrete significant amounts into their culture 
medium, possibly due to proteolytic enzyme degradation, but Fn 
is more likely to be found as fibrillar networks between cells 
and between cells and substratum (Hynes and Yamada, 1982).
Fibronectin is a multi-functional protein (Paul and
Hynes, 1984; Yamada  al, 1985) and in addition to promoting
cell adhesion (Piershbacher .e,.t ..a.l, 1982; Yamada, 1983), has
several binding sites for various components including DNA 
(McMaster and Zardi, 1982), collagen (Yamada, 1983),
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proteoglycans (Yamada, 1903) and bacteria (Van de Water, 
1983). The various domains of fibronectin are shown in Fig 6 
(taken from Yamada , 1984) .
Extensive amino acid sequencing of cellular fibronectin 
has not been possible since it is less abundant than plasma 
fibronectin. Information on the primary sequence of
fibronectin and elucidation of the origin of the differences 
between the Fn subunits have therefore come from the 
sequencing of cDNA and genomic clones of plasma Fn (Petersen
et ai, 1983; Skorstengaard  ai, 1984; Kornblihtt, 1983).
Ninety percent of the primary structure of plasma fibronectin 
consists of a series of homologous repeats. See Fig 5 (taken 
from Hynes, 1985) . There are three types of repeat: Type I, 
Type II (disulphide-bonded loops, each 45-50 amino acids long) 
and Type III (90 amino acids long with no disulphide bonds) . 
There are 12 Type I homologies, 2 Type II homologies and 15-16 
Type III homologies. Differences in the subunits are shown in 
Figs 5 and 6. In evolutionary terms, the repeating homologies 
strongly suggest that the Fn gene arose by endoduplication of 
several primordial minidomains, corresponding with the present 
day homology of Types I, II and III (Odermatt .e..t......al, 1985).
The recombinant DNA analyses reveal that although the 
subunits do differ in parts of their primary sequence, they 
all arise from a single gene, and are identical over much of 
their sequence. The structure of the Fn gene is extremely 
complex, comprising of approximately 50kb of DNA and 50 exons 
(Hynes, 1985). The precise correspondence between exons and
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homologous repeats has yet to be defined. The variations in 
fibronectins must arise from alternative splicing of the 
primary transcript. One gene can give rise to 6-10 different
variations (Tamkun  al, 1984). Different cell types can
apparently regulate this alternative splicing (Hynes, 1985) 
but it remains unclear how or why they do so.
The reason for interest in the cell adhesion promoting 
properties of Fn arose from its apparent involvement in a 
variety of biologically important functions. For example, 
there is a good, but not perfect correlation between 
transformation and loss of Fn (Vaheri and Ruoslahti, 1975).
Loss of Fn also correlates with tumorigenicity in..„ vAkq. (Chen
- 1976). Investigations designed to elucidate the
significance of the loss of Fn for the transformed phenotype 
(Yamada 1976) revealed a role for Fn in cell adhesion.
For example, addition of purified Fn to transformed cells 
which lack it, produces increased cell attachment. A role of 
fibronectin in cell adhesion was also shown by studies of the
role of serum in cell adhesion (Klebe e.t a.l, 1978, Hayman .e..t
al, 1982). Many cells require serum in order to attach in 
culture, either to plastic or collagen and the serum component 
responsible for this appears to be Fn (Klebe, 1974; Kleinman 
1978; Grinnell and Hays, 1978).
The cell attachment region of Fn was determined by 
Ruoslahti (1982), who proteolytically digested fibronectin, 
until only a small peptide remained which still retained cell
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adhesion activity. By making synthetic oligopeptides to the 
digests, Piersbacher and Ruoslahti (1904) found that the 
peptide consisted of Arg-Gly-Asp (RGD). Knowledge of the 
active site of the ce 11-attachment domain has also facilitated 
investigations of the cellular side of this interaction. In 
its free form the RGD peptide inhibits cell attachment, but 
when coupled to a substrate via a spacer arm, the RGD peptide 
promotes adhesion of cells to the substrate (Ginsburg ,
1985). (See Fig 7).
Other cell adhesion regions are also thought to exist. 
In rat Fn, expression of a second RGD sequence was found to be
controlled by alternative mRNA splicing (Schwarzbauer e..t «1,
1983), raising the possibility that some Fn molecules have 
two, if not several cell attachment sites. In melanoma cells, 
attachment to Fn occurs through an REDV site (Humphries et al.
1986) which is found in domain V of human Fn. In rat Fn the 
sequence is RGDV, which is also found in domain V.
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Fig 5 shows the primary structure of Fn
73
30K 40K 20K 75K
M
Fig 6 The functional domain structure of fibronectin.
1 Binds to a variety of ligands including heparin, fibrin, 
act in, transglutaminase and
2 Collagen binding domain
3 Weak fibrin binding site - easily destroyed by proteases
4 Cell binding - the middle fragment has a high degree of 
homology between species. The actual binding site is 
thought to consist of three amino acids, ARG-GLY-ASP 
(RGD)
5,6 There is a difference in the dimers at this point which
is a possible requirement as a recognition mechanism 
between complementary sites on the subunits, which would 
function during the assembly of a dimeric fibronectin 
molecule from monomers. This domain also contains 
heparin and fibrin binding sites.
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shows the effect of the RGD peptide on adhesion of
In addition to promoting cell adhesion (Martin and 
Timpl, 1987), Lm has binding sites for collagen Type IV (Rao 
, 1982) , heparin sulphate (Woodley 1983) , nidogen
(Pauisson , 1987) , bone osteonectin (Mason 1986) ,
complement components Clq and C3 (Bohnsack  ,al, 1985; Leivo
and Engvall, 1986) and plasminogen and plasminogen activator 
(Salonen  al, 1984) .
Laminin is a glycoprotein (Mr lOOOkD) found 
predominantly in basement membranes and is synthesized by 
epithelial cells. It consists of three alpha chains of 200kD
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and one beta chain of 400kD held together by disulphide bonds 
(Kleinman 1984) . It has a cruciform shape as shown in
Fig 8. Digestions of Lm by various proteases and
characterisation of the large fragments by electron microscopy 
and immunochemical methods have proved useful approaches for
dissecting the multi-domain structure of Lm (Timpl e..t .al,
1983; Martin and Timpl, 1987).
cDNA clones have been isolated and some primary 
sequences have been obtained (Barlow 1984; Pikkarainen
et al . 1988) . The primary structure of Lm is shown in Fig 9 
(taken from Martin and Timpl, 1987). Information from the B1 
arm shows that Domains I and II are alpha-helical structures 
of about 600 amino acids (interrupted by 6 cysteine residues 
whose function is unknown, but may involve neurite outgrowth 
or cell attachment). Domains III and V are cysteine rich and 
consist of 50 amino acids. This repeat structure occurs 5 
times in V and 8 times in III. This type of cysteine rich 
repeat structure is also found in precursor EGF, coagulation 
factors and thrombospondin (Sasaki et aJ. 1987) . Domains IV
and VI consist of 250 amino acids, are low in cysteine 
residues and are thought to be the globular regions.
' The size difference between the B2 and B1 arms is about 
190 amino acids, but shows the same arrangement of domains
(Martin and Timpl, 1987; Pikkarainen e..t al, 1988) . Other
differences include a lower number of EGF-like repeats and the 
absence of the 6 cysteine residues. B2 and B1 are therefore 
the products of related but distinct genes that are probably 
derived from a common ancestor gene. The question is raised
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that since B2 and B1 have different biological activities it 
is also possible that different molecular species exist as is 
found for Fn. The characterisation of the A chain is still 
incomplete but it is known that the N-terminal segment shares 
homology to comparable domains in the B1 and B2 chains 
(Pikkarainen e..t al, 1988) .
heparin binding
215kD
cell attachmentaxon outgrowth
CDPGYIGSR
400kD
50kD
heparin binding site
205 kDh^arin binding
collagen binding
melanoma 
cell attachment ^  Cl fragment
Fig 8 The functional domain structure of laminin.
Dom ains V I  V  D l
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Globular Homologous Cysteina- 
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Fig 9 shows the primary structure of Lm.
COOH
78
In common with Fn, Lm promotes adhesion of some cells
(Terranova .e..t_. fll, 1982) . Information about the amino acid
sequence of Lm has revealed a specific nonapeptide binding 
site known as the CDPGYIGSR site after the amino acid sequence
of the active peptide region (Rao ,e..t al, 1982; Graf ...ai,
1987) which promotes epithelial cells to adhere to Lm. This
binding site is found in domain III of Lm (Graf fit „a,.i.. 1987)
and was able to inhibit attachment of the cells to Lm by up to 
80%, indicating that it is one of the major sites of cell 
attachment in Lm.
There has been some controversy as to whether the cell 
attachment site in Lm involves an RGD peptide as it does in 
Fn. However Ruoslahti (1988b) has presented evidence for its 
existence. The evidence is that the RGD peptide in its free 
form can slightly inhibit cell adhesion to Lm (Ruosalahti. 
1988a) . Since the RGD sequence has not been found in either 
the B2 or the B1 arms, it is probably located in the A chain.
Skubitz §± a..I, (1987) described another cell adhesion
domain in Lm. Using antibodies to chymotryptic fragments of 
Lm, they found an antibody which reacts to a region close to 
the cross region of the long arm of Lm. This antibody 
inhibited adhesion of murine metastatic melanoma cells 
(K1735M4). This adhesion site is also a heparin binding site, 
as determined by the same antibody (Skubitz .fi..t.....„.a.1, 1988) . In 
addition to this heparin binding site, three others are shown 
in Fig 8. The complex process of cell adhesion to 
extracellular matrices may depend on heparin binding since
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other extracellular matrix molecules also have heparin binding
sites; such as vitronectin (Suzuki ,fi.t , 1985) ,
thrombospondin (Dixit  a.l, 1984), von Wi 1 lebrand factor
(Fuj imura  al, 1987) and fibronectin (Yamada, 1983). The
extracellular matrix molecule interaction with heparin might 
be used in conjunction with or as an alternative way for cells 
to adhere rather than just by the known adhesion sites.
Vitronectin is found in the form of two non-covalently 
bound polypeptides (65kD and 75kD) on the surfaces of many 
cells (Owens and Miller, 1980; Tu 1 lis 1981; Barnes and
SiInutzer, 1983), in the extracellular matrices of various
tissues (Hayman / 1983; Simonton .fit .al, 1985) and in
serum (Hayman fi.t 1985). In addition to promoting cell
adhesion (Yamada et ai. 1985) , Vn is also thought to have a 
role in the latter stages of the complement and coagulation 
pathways (Jenne fi.t.._a.I, 1985) . It should be noted at this
point that S protein found in serum and vitronectin are 
immunological ly and functional ly the same (Tomasini and
Mosher, 1986; Hayman .fit. 1985) . Vn binds to a thrombin-
anti thrombin III (82kD) complex (111 and Ruoslahti, 1985;
Jenhe ,e.t„ ,fil, 1985). The anti thrombin (ATI II) (58kD)
glycoprotein is a major protease inhibitor for the coagulation 
system and functions by binding to thrombin (Marcum and 
Rosenberg, 1985). Binding of Vn to this complex probably 
results in protection of thrombin from inactivation by ATI 11. 
The binding of thrombin-AT111 to vitronectin also exposes an
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extra heparin binding site on vitronectin (Preissner 
1985) . It may be that the heparin binding site serves to 
increase the affinity of the interaction of the extracellular 
molecules with the cell surface by binding to heparin sulphate
proteoglycan in the plasma membrane (Yamada fit fil, 1985) .
Vitronectin also binds to various complement components - 
C5b7, C8 and C9 (Bhakdi and Roth, 1981; Jenne and Stanley, 
1985).
The structure of vitronectin is shown in Fig 10 (taken 
from Juliano, 1987) . The domain structure for Vn has been
elucidated by Suzuki fit fil (1984; 1985) and Jenne and Stanley
(1985). This analysis reveals no sequence homology between Vn 
and Fn except with an RGD peptide. Another homology is 
observed with somatomedin B over the first 30 amino acids at 
the NH2-terminal.
The cell adhesion function of Vn is thought to be 
mediated by the tri-peptide RGD (Suzuki .fit.........fi.1, 1985) . Further
evidence comes from the inhibition of cell adhesion by the RGD 
peptide (Ruoslahati and Pierschbacher, 1986). In addition
since plasma vitronectin binds to an anti-thrombin
111/thrombin/heparin complex (Choay fi„t fil, 1983: 111 and
Ruosalahti, 1985 ; Lane fi..t.„...fii., 1987; Carlsson fi.,t.......fii, 1988), and
since, anti thrombin III (ATI 11) has been shown to be produced 
by endothelial cells (Owens and Miller, 1980) and malignant
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cells (Tullis .at .al, 1981) it is thought that in some way this
interaction may facilitate cell adhesion.
RGD
-5kD
N
somatomedin
65kD
heparin binding __12kD
Fig 10 The domain structure of vitronectin.
3„.,„1....4,. Other g lycoproteins
There are several other extracellular matrix 
glycoproteins which have been implicated in cell adhesion, and 
which interact with and have properties in common with Fn. Lm 
and Vn. (See TABLE 1) . These glycoproteins include 
fibrinogen (Doolittle, 1984), heparin sulphate (Birdwell at.
, 1978) and entactin (or nidogen) (Dziadek , 1985) .
More recently, other molecules have been increasingly reported
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in the literature, and include thrombospondin, tenascin and 
von Wi1lebrand factor (see below).
Thrombospondin is secreted by a variety of cells (Dixit
1984;), including endothelial cells (Mosher fit. fil,
1982; Raugi et ai. 1982) and is also a platelet alpha granule 
protein, secreted on platelet activation (Lawler fi.t......a..I, 1978) .
It consists of three polypeptides of Mr 180kD (Dixit fi...t._..fi.I,
1985) and some domain organisation (Coligan and Slayter, 1984) 
and stretches of protein sequence have been determined (Dixit
fit a.i, 1984) . It is known to bind heparin (Lawler fit .«1,
1978) , collagen (Lahav et, aJ., 1982), fibrinogen (Leung and
Nachman, 1982) and fibronectin (Lahav ,fi.t .fil, 1982) . In
addition it causes attachment in some cells including melanoma
cells (Varani e,t. .aJ., 1986; Roberts .fit .ai, 1987; Riser ..fit. ,
1988). i
Tenascin (240kD) is an extracellular matrix molecule,
found in various tissues (Thesleff fit .a..l, 1987; Maier and
Mayne, 1987; Mackie and Thesleff, 1987). It has a "six arm" 
structure which would enable it to have multiple interactions 
with ECM components and to be involved in cell attachment. 
However, it has the least activity of the extracellular matrix 
(ECM) molecules (Chiquet-Ehrismann, 1988) . It is also
involved with cell aggregation (Chiquet and Fambrough, 1984; 
Chiquet-Ehrismann .e,.t.„,...al, 1986) .
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Von Wi 1 lebrand. factor (220kD) is a disulpbide linked 
glycoprotein, synthesized by endothelial cells and 
megakaryocytes and is also found in plasma, as a component of 
the sub-endothelium and in the alpha granules of platelets 
(Santoro, 1987). There is no sequence homology with any other 
proteins except as regards an RGD sequence (Ginsburg ,
1985; Gartner and Bennett. 1985) which may promote the 
adhesion of platelets to endothelium (Santoro, 1987). there
is, however, a lot of internal repetition (Bonthron fit,. .a,I,
1986 ; SheIton-Inloes fit. .fil, 1986).
In summary, these adhesion promoting proteins are large 
complexes with a variety of functions. They share common 
structural/functional features and are comprised of a series 
of proteinase stable functional domains which have binding 
activities for other macromolecules, linked by proteinase 
sensitive interdomain regions. The question of the possible 
homology of these glycoproteins with each other is of some 
interest and the information on this is beginning to 
accumulate at an increasing rate. Most, if not all these 
molecules, contain an RGD sequence(s) (reviewed by Ruoslahti 
and • Pierschbacher, 1986) which is thought to be involved in
cell attachment. This RGD sequence is also found in epidermal 
growth factor (EGF) and beta-transforming growth factor (TGF) 
precursor (Gartner and Bennett, 1985).
TABLE 1
Interaction of extracellular matrix proteins with other components
Glycoprotein Mr Interaction
Type IV collagen 550k-600kD heparin sulphate and Fn
Laminin lOOOkD proteoglycans, entactin, 
actin, collagen type IV, 
heparin sulphate
Heparin sulphate 550k, 300k and 230kD collagen type IV, Lm and Fn
Chondroitin sulphate 200k-300kD Vn
Entactin 150kD Lm, Fn and Coll
Fibronectin 440kD CoU types I-V, fibrin, actin and heparin sulphate
Vitronectin 75k, 65kD chondroitin heparin SO/ and anti Till
Tenascin 240kD fibronectin, proteoglycans
von Willebrand factor 270kD collagen
Thrombospondin 580kD collagen, Fn fibrinogen thrombin and vWF
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Since the RGD sequence appears to be the common link 
between the extracellular matrix proteins previously 
discussed, it would seem appropriate to consider the receptors 
for this sequence first. The RGD receptors appear to belong 
to a super family, all in the 100-160kD range which consist of 
transmembrane glycoprotein receptors for extracellular matrix 
proteins. They share common structural an functional features 
and are thought to link the cytoskeleton to the extracellular 
environment; thus they have been called "integrins". This 
name was coined for them by Hynes (1987) and his 
classification of the RGD receptors and related proteins is 
based on DMA sequence information and immunological cross 
reactivity.
The RGD receptors (or integrins) generally consist of 
two beta chains and two alpha chains (Juliano, 1987). The RGD 
receptor is found on the surfaces of a wide variety of cell 
types (Ruoslahti, 1988) including platelets (glycoprotein
11 a/nib or gp II a/nib) (Bennett  Al, 1983), M21 human
melanoma cells (Cheresh and Spiro. 1987), avian fibroblast 
cells (cell substrate attachment antigen - CSAT) (Horwitz e.fc 
ai., 1986) macrophages (MAC-1) (Juliano. 1987) , dms,QRhiJ..a 
epidermal cells (PS antigen) (Leptin. 1986) lymphocytes (LFA- 
1) (Ruoslahti and Pierschbacher. 1986) and T-cells (VLA)
(Takada et al, 1987). It also arises in the lambda receptor
of (Charbit .e..t. .«1, 1984) and in some viruses - yellow
fever and foot and mouth (Ruoslahti. 1988b).
The cellular RGD receptor for Fn has been difficult to
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elucidate, largely because the binding of cells to Fn is of 
relatively low affinity (e.g. Ko 8x10“’’ in fibroblasts)
(Akiyama and Yamada. 1985) . Pytela e.t..aJ. (1985a) . proposed
protein (s) of Mr 140kD (non-reduced) and 160 and 120kD 
(reduced) as the receptor for Fn. The direct binding of Fn to 
these proteins and the inhibition of Fn-binding to the 
proteins by the RGD peptide support this model.
In the case of Lm, there may also be a cell adhesion
receptor in the integrin family (Gehlsen e..t„ .«1, 1988).
However, much less is known about the RGD receptor in Lm and 
until recently it was not though to exist. Two polypeptides 
with affinity to Lm have been described with Mr of 120kD and
180kD (Kleinman e,t al• 1988: Smalheiser and Schwartz. 1987)
and it is yet to be seen whether these bind to the RGD 
sequence in Lm.
The cellular RGD receptor for Vn consists of two chains 
of llSkD and 125kD (reduced conditions) and were isolated 
using a hexapeptide containing RGD peptide (Pytela
1985b). The degree of homology between the amino acid 
sequences of the larger subunits of the RGD receptors for Vn 
and Fn is between 34-48% (Martin and Timpl, 1987).
The integrin sequences which have so far been
characterised, are the alpha and beta subunits of human Fn
receptor (Argraves  «I. 1986) , the alpha and beta subunits
of Vn (Suzuki  aj., 1987), the alpha and beta subunits of
gpIIb/IIIa (Poncz  a.1. 1987) and the beta subunit of CSAT
(Tankum .e.,.t ,al. 1986) .
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From this and immunological information it can be seen 
that the beta subunit is conserved (Fitzgerald . 1987;
Ruoslahti, 1988b). For example, the Fn receptor, VLA and 
avian integrin are thought to be related and their beta 
subunit is termed beta 1. The MAC-1 and LFA-1 receptors are 
related and their beta subunit is termed beta 2. The Vn 
receptor and gpIIb/IIIa are related and their beta subunit is 
termed beta 3. There are also 10 alpha bands which are
distinct and which are denoted by the nature of the ligand
i.e. alpha-.R is the alpha subunit for fibronectin. The alpha
subunits of each integrin contains several sites that are
homologous to calcium binding site in other proteins 
(calmodulin). Fig 11 (taken from Ruoslahti. 1988b) shows a 
proposal for the structure of an RGD-receptor. Calcium is 
known to bind to gpllb, Fn and Vn, and is important in the 
role of receptors (Oppenheime r-Mark s and Grinne11. 1984;
Edwards  .a.i, 1987; Ruoslahti. 1988b). Other divalent
cations might also be important - for example, manganese. It 
had been thought that the Fn RGD receptor was only specific to 
Fn; however a recent article by Gailit and Ruoslahti (1988) 
suggests that manganese enhances binding of the Fn receptor to 
other RGD-containing proteins.
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Fig 11 shows the structure of an RGD-receptor.
It is thought by Ruoslahti and Pierschbacher (1986) that 
divergent evolution gives rise to multiple mammalian receptors 
that have subtly different specificities. In contrast, the 
adhesion proteins may have arisen through convergent evolution 
by means of simple mutations, since these proteins do not seem 
to share other homologies.
Other types of cell receptors to the extracellular 
matrix also exit. These are of lower molecular mass than the 
RGD receptors. For example in melanoma cells, attachment to 
Fn is achieved through an REDV site (Humphries 1986)
and since the RGD receptors are highly specific, there must be 
another receptor for this site which has not yet been
89
elucidated. Another candidate for a low Mr receptor for Fn is 
a 47kD glycoprotein found in BHK cells (Yamada e.t,„,...aX. 1985) .
Much more is known about the low molecular weight 
receptors to Lm. A high affinity receptor to Lm has been 
described, which is thought to bind the CDPGYIGSR peptide (Ka
2 X  10“*^ M) (Brown e . t  a . l , 1983; Von der Mark and Kuhl, 1985)
and has been found in various cells including melanoma cells. 
This receptor has a Mr of about 68kD under reduced conditions
(Rao ,e..t aj . , 1983) and has been partial ly characterised (Kitten
,et al, 1986) .
A cellular receptor for TSP has recently been discovered
(88kD) in platelets (Asch  , 1987) which appears to be RGD-
independent. Similarly a platelet receptor for vWF (150kD) 
has been described (Santoro, 1987).
There are also numerous polypeptides of Mr 31kD, 47kD, 
65kD and 75kD, which show an affinity for collagen (Yamada .e.fc 
ül., 1985 ; Juliano , 1987).
Little is known of the regulation of any of these 
adhesion receptors in terms of expression or function. 
However, there is increasing evidence of their possible 
regulation by protein kinases. For example, there is a 
tyrosine kinase site on the CSAT antigen in RSV-transformed 
cells which becomes phosphorylated by pp60src. Other 
observations have led to the suggestion that both cAMP- 
dependent protein kinases (Cheung and Juliano, 1985; 1987) and 
C-kinase (Juliano, 1987) may also regulate Fn-dependent 
adhesion. It is not certain if the effects of cAMP-dependent
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kinase or C-kinase are mediated at receptor phosphorylation 
level or if it is post receptor elements of the adhesion 
pathway which are regulated by these kinases (Juliano, 1987). 
It is possible that amongst the membrane receptors for 
extracellular components that there is growing evidence for a 
similar type of "cross talk", as occurs in the case of hormone 
and growth factor receptors, where there are numerous examples 
of the stimulation of one receptor affecting the behaviour of 
another.
Cell adhesion molecules may be important in a variety of 
interactions occurring in the metastatic process. For example 
once tumour cells detach from the primary mass and are 
released into the circulatory system (Sherbert. 1982), they 
can interact with normal cells such as lymphocytes (Fidler,
1975), platelets (Pearlstein  «1» 1980) and thromboplastic
components (Kohga and Tanaka, 1979). Tumour cell aggregation 
with platelets may involve Fn, thrombospondin and von 
Wi 1lebrand factor which are secreted from platelets following 
activation by thrombin or collagen (Zucker, 1979; Dixit ,
1985; Ginsburg, 1985b). It is possible that these molecules 
on the surfaces of platelets cause tumour cells to become 
attracted to them. An example of this might be found on M21 
melanoma cells which have an RGD receptor which can recognize 
Vn, fibrinogen (Fg) and vWF (Cheresh and Spiro, 1987). On the 
other hand, the RGD binding receptors gpIIa/IIIb on platelets 
may be used for recognising the RGD sequences on Vn, Fn, Fg or
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vWF on tumour cells or in serum, in order to form stable 
tumour cell aggregates.
Receptors on the tumour cell surface may then be 
involved in implantation of blood-borne tumour cells to Vn, Fn 
and vWF on the endothelium (Nicolson and Winklehake. 1975;
Phondke e± a.l, 1981; Net land and Zetter, 1986) , and may induce
the endothelial cells to withdraw from each other, thus 
exposing patches of the underlying basement membrane 
(Kawaguchi e.t. al. 1985) .
Following adhesion, tumour cells may utilise Fn, Lm and 
Vn receptors to migrate through the BM (Liotta, 1986; McCarthy 
et ai, 1985) since these adhesion proteins have been shown to 
affect the motility and migration of the tumour cells. 
Further evidence for the role of adhesion proteins in 
metastasis has come from inhibition of formation of 
experimental métastasés by use of the RGD peptide. The 
mechanism of RGD anti-metastatic effects, however, remains 
unelear.
In tumour cell adhesion, emphasis has been placed by a 
number of workers, on Lm and Fn receptors, who have reported 
differences in the abilities of high and low metastatic lines 
to adhere to extracellular matrix molecule. They have also 
shown differences in the abundance and/or composition of the 
ce 11-surface glycoproteins of these cell lines (Terranova e.t
a.1, 1984) . Interactions of adhesion promoting proteins with
receptors on the cell surface can modulate the adhesive, 
motile, invasive and metastatic behaviour of tumour cells.
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Thus Terranova ,e..t jStJ. (1982) found that exposure of B16 cells
to laminin ,lo .o...tr.a enhanced binding of the cells to the
endothelium and metastatic ability increased. On the
other hand, Nicolson .e.t al, (1981) showed that exposure to
fibronectin reduced laminin binding and reduced metastasis.
Another question still to be answered is how the 
adhesiveness of cells can be modulated. Since the various 
adhesion promoting glycoproteins discussed are ubiquitous, it 
is difficult to understand how tumour cells can adhere at 
tissue-specific sites in order to form secondary deposits. 
One obvious way would be to vary the number of adhesion 
receptors expressed at the cell surface. For example, an
experiment by Reiber  al. (1986) demonstrated that melanoma
cells were unable to attach to collagen type I and formed 
aggregates even in the presence of Fn. In these aggregated 
cells, the Fn receptor (140kD) was much decreased in 
expression. There may also be a difference in expression of 
Lm receptors. For example, there are more Lm receptors in 
breast carcinoma than normal breast tissue (Hand et aJ. 1985). 
Other possibilities might involve modulation of surface 
display of adhesion receptors (degree of clustering or 
interaction with other membrane components) (Aplin and Hughes, 
1981). There is also a difference in distribution of Lm 
receptors between benign and malignant cells, e.g. in breast 
cancer the benign tumours express their receptors at the base 
of the cells adjacent to the basement membrane whereas the 
malignant cells express their receptors over the entire 
surface of the cell (Hand e.t .«1, 1985).
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However, Brown and Juliano (1986), described the 
situation where ample 140kD protein is expressed but adhesion 
still does not take place. This maybe due to tyrosine 
phosphorylation (as occurs in transformed cells) or control by
c AMP-dependent kinases and protein kinase-C (Saga  ,
1988).
The aim of this part of the study was to find a suitable 
means of extracting molecules from the surface of endothelial 
cell monolayers and from the conditioned medium without 
destroying any adhesion-promoting activity of the molecules. 
In a study by Hatcher (1986), endothelial cells were
grown in serum-free medium and 20 hours later the conditioned 
medium was removed and tested for adhesion promoting 
molecules. Since this seemed to be a rather detrimental 
procedure to the cells, which could result in the release of 
toxins as the cells started to die, it was decided that the 
cell surface proteins should be extracted using EDTA and to 
concentrate the conditioned medium. In order to determine 
which molecules were derived from the cells and which were 
derived from the serum, cell-free controls were run 
concurrently.
The next step was to develop a suitable assay for 
testing adhesion. Adhesion assays described in the literature 
are based on the adsorption of putative adhesive molecule(s) 
onto an artificial substrate such as plastic or
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nitrocellulose, followed by incubation of the molecule with a 
suspension of cells. The first use of this kind of adhesion 
assay was performed by Klebe (1978) , whereby serum was
electrophoresed on cellulose acetate and a diffusion replica 
made by overlapping onto a gel of 0.25% type I collagen. 
Molecules not bound to collagen were washed away and the bound 
molecules to the collagen were incubated with Chinese hamster 
ovary cells for a fixed time of 90mins at 37®C. The replica 
was then rinsed, fixed and stained (0.1% toludine blue). Two 
adhesive bands were identified in this way: one by its
isoelectric point (pi 4.8) and the other by its extremely 
large size (failure to run into the gel). The major drawback 
of this study was that only adhesive molecules with collagen- 
binding properties would be detected.
Hayman efc ai. (1982) developed this technique further by
separating plasma proteins (depleted of albumin and IgG) using 
SDS-PAGE, followed by diffusion blotting of the separated
proteins onto nitrocellulose (as described by Bowen e„t._.
1980) . The blot was then incubated with rabbit kidney (NRK) 
cells, fixed and stained (0.1% amido black). Two adhesive 
proteins were identified with Mr of 220kD and 70kD 
(corresponding to fibronectin and vitronectin respectively).
One of the limitations pointed out by Hayman e.t .al (1982) was
that the properties of the adhesion promoting proteins could 
be destroyed by treatment with SDS and reducing agent such as 
mercaptoethanol (2-Me).
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In this study, adhesion promoting molecules extracted 
from the endothelium were initially probed with B16F10 cells, 
in the presence of divalent cations, in a dot blot assay which 
was developed for quick determination of the extent of the 
adhesion promoting activity of molecules. An advantage of 
this assay was that problems associated with blotting
techniques could also be investigated (Appendix 3) . One such 
problem was associated with the use of SDS and 2-Me as pointed 
out by Hayman .e..t di. (1982) .
Having shown that these molecules could promote 
adhesion, verification could be obtained by using an
immunological approach. This involves the production and
characterisation of anti-cell surface antibodies which inhibit
adhesion (Damsky et aï, 1979; 1982 Knudsen et al. 1981). These
workers developed polyclonal antibodies to fibroblasts which 
caused cell rounding and detachment. They then extracted
fibroblast membrane glycoproteins which could block the 
antibody activity. During the last 15 years, laboratories 
have produced a variety of polyclonal antibodies which can 
inhibit cell-cell adhesion or prevent the interaction of cells
with extracellular components (Goodman e..t al, 1983; Edelman,
1983) . The dot blot assay system developed in this study 
could also be adapted for use in testing antibodies, raised to 
adhesive molecules or to cell surface molecules, for their 
ability to inhibit adhesion.
Having established that the extracted molecules promote 
adhesion they could then be characterised by SDS-PAGE and
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immunoprobing in order to determine whether they are known 
adhesion-promoting proteins such as Fn, Lm, Vn, or a new 
protein.
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All chemicals used were obtained from BDH and were 
Analar grade, unless otherwise stated.
 .extract,1,0.0
fiü.)., ,Ei.b,,roo.e,.d.ti.,n..
Obtained from Dr N. Hunter (Scottish Blood Transfusion 
Centre, Edinburgh).
Laminin was purchased directly from Sigma.
Cell extract was prepared from BAE cells seeded at
б. 5 x 1 cells and grown to confluence (3 days) in roller 
bottles (growth area 750cnP). The roller bottles were gassed 
for Imin with 95% air, 5% COs and rolled at O.Srpm. The spent 
medium was retained (cell extract medium - CEM) . Each bottle 
was washed once with 30ml calcium- and magnesium-free 
phosphate buffered saline (CMF-PBS) before extracting the 
confluent monolayer with 25ml 2mM EDTA in CMF-PBS for lOmin at 
37‘=’C (cell extract - CE) . (See Fig 12) .
Initially the extracted proteins were concentrated 
against aquaeide III (flake polyethylene glycol, Mr 8kD, 
Behring Diagnostics), until reduced lOx and then dialysed
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against PBS overnight at 4°C. However, it was found that CE 
precipitated irreversibly upon concentrating. A new protocol 
was adopted whereby the proteins were concentrated to half the 
initial volume, dialysed against distilled water overnight 
before concentrating as already described. This reduced the 
amount of precipitation and so enabled the proteins to be 
filter sterilised without loss of protein. For some 
experiments CE which had been concentrated by the former 
method, were used. In this case it was denoted BAE Ext. (See 
Fig 12).
Roller bottles containing medium but no cells, incubated 
under the same conditions as above, were extracted in the same 
way to give an indication that the effects observed were due 
to cell-derived or serum-derived components.
Fig 12 shows the procedures used in the extraction
of CE, BAE Ext and CEM.
BAE cells 
roller bottle
3 days growth
c o n d i t i o n e d
m e d i u m
B  concentrated
CEM
O.Srpn
2mM EDTA
lOmln 37**C
c e l l  s u r f a c e  e x t r a c t
B  concentrated CE
o r  BAE Ext
O.Srpn
2mM EDTA
concentratedlOnin 37‘*C
- CE2
c e l l  a n d  g l a s s  e x t r a c t
spun at 4 C 
240g
CONCENTRATION PROCEDURE
T O  O B T A I N  C E M ,  C E I  a n d  C E 2
B A E  E x t
concentrated against 
aquacide III 
at roo# temperature 
until reduced to 
half the initial volume
dialysed overnight 
against water 4=C
concentrated against
aquacide 111 at 
room temperature
until reduced lOx
concentrated against
aquacide III at 
room temperature
until reduced 1Qx
dialysed overnight 
against PBS 4“CI
spun at 
240g 4»C 
for 20min
/ \
supernatant precipitate
dialysed overnight 
against PBS 4"C
filter sterilised
filter sterilised
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Protein samples containing SDS at a final concentration 
of 0.625% were boiled for 2min (non-reduced conditions), and 
in some cases 2-mercaptoethanol (2-Me) was added (final 
concentration 10%) and the solution boiled for a further 2min 
(reduced conditions). The non-reduced and reduced samples 
were separated on slab gels (without stacking gel) using an 
adaptation of the Laemmli method (Laemmli, 1970).
Each gel cartridge consisted of two sheets of glass 
separated by plastic spacers on two sides and held together 
with sticky tape. The gel solution was made up according to 
the range of molecular masses present in the sample (i.e. 
higher Mr proteins were run on lower percentage aery1amide 
gels). See Appendix 1.
The electrophoresis running buffer contained 0.025M 
tris-HCl, 0.192M glycine and 0.01% SDS, pH8.3.
Protein samples (40ul/well) containing 10% glycerol were 
run at 50mA/gel for about 4h on gels (7.5 x 15 x 1.5mm). 
Molecular weight standards (Sigma SDS-7) were run 
simultaneously if the molecular masses were being determined.
In order to visualise protein bands, the gels were fixed 
in 7% acetic acid in distilled water for 30min immediately 
after electrophoresis and stained overnight in 0.02% Coomassie 
blue in 7% acetic acid. The gels were destained in 25%
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methanol and 10% acetic acid in distilled water. At this 
stage the gels were dried down and photographed.
Polyacrylamide gels were placed into a plastic sandwich 
box containing a 500ml slurry of aquacide III (flake 
polyethylene glycol, Behring Diagnostics) in distilled water 
(Ig/ml) and left at room temperature until reduced about 16X. 
The amount of time for dehydration was a function of the 
percentage of aery 1 amide in the gel: it took about 12 min for 
each percent of aery 1 amide (Ferro et ai, 1909 - see Appendix
4). The dehydrated gels were rinsed in distilled water and 
placed on filter paper (Whatman No 2) in a gel drier 
(Pharmacia) with a hot air blower placed about 15cm above the 
gel. Four gels could be processed at one time. The gels were 
left to dry completely for three hours and then left under a 
1kg weight overnight before being stored permanently.
Following electrophoresis, gels were placed in tris- 
HCl/glycine buffer pH8.3 (with 20% methanol in the case of
SDS-containing gels). The blotting sandwich consisting of a 
Scotchbrite pad, Whatman filter paper No. 2, nitrocellulose 
paper (Mil lipore cat. no. HATF 13750, pore size 0.45um), the
gel, and another Whatman filter paper and Scotchbrite pad was
lowered into the blotting tank (Biorad). The nitrocellulose 
was placed to the anodal side and blotting carried out for
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30min at lOOV. A strip of nitrocellulose was cut and stained 
in 1% ami do black for 3min to check that protein had been
transferred. Destaining was carried out in 70% ethanol to 
visualise transferred proteins.
 C.t.1.1 attachment
Proteins were dotted onto nitrocellulose discs as 
described in Part 2.2.3a and the discs placed into a 24-we11
plate. The upper chamber (consisting of a bottomless 5ml
Teklab tube) was placed over the discs and 1ml 10% BSA in 
distilled water was used to block the filters for 30min at
37':'C. (See Fig 13) .
The cells were harvested as usual and resuspended in 
serum-free EC medium to 1x10* cells/ml. 1ml of cell 
suspension was placed into each chamber and left at 37^0 for 
90min, after which the discs were placed in CMF-PBS, followed
by 2mM EDTA for 2min and finally washed extensively using 10ml 
PBS dispensed from a 10ml syringe through a 19 gauge needle. 
The cells attached to the filters were then stained as 
described in Appendix 1 and the dried filters mounted in 
emulsion oil so that the cells could be observed using light 
microscopy.
Western blots of gels containing adhesion promoting 
proteins were blocked with 10% BSA in distilled water for
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30min at 37*:^ C. The blots were then cut in order that one 
track fitted into a plastic holder with a fitted upper chamber 
which was 1ml deep with a total volume capacity of 20ml (See 
Fig 14). The B16F10 cells were harvested and 10ml of cell 
suspension (1x10* cells/ml) was placed into the upper chamber 
and left at 37'^ 'C for 90min. After this time the filter was 
placed into CMF-PBS, followed by 2mM EDTA for 2min to remove 
cells which had bound non-specifically to the substrate and 
then washed extensively using 50-100ml PBS dispensed from a 
20ml syringe through a 19 gauge needle. The filter was 
stained and mounted as for the dot blots (Part 3.2.4a). (See 
Fig 15).
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Fig 15 shows the protocol used in cell attachment.
ADHESION
dot blot of proteins to 
test adhesion activity
telectrophoresis of protein1
gel Western blottedIWestern blot incubated 
with 10% BSA for 30min at 37^C
fCells incubated with Western blot for 
90min at 37<*CI2mM EDTA treatment for 2min. Washed with PBSIfilter stained and dried
Imounted in emulsion oil
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The method was followed as described in Part 2.2.3a 
except that 2ul of protein solution (various dilutions made u p  
in PBS) was dotted around the circumference of each of the 
discs.
The method as described in Part 2.2.3b was followed with 
the following modifications. Instead of using cells, lOOul of 
protein solution, made up to a final concentration of 20ug/ml 
in carbonate-binding buffer pHll.O (see Appendix 1). was
incubated in each well of a 96-well plate for 2h at 37°C. The 
first row was used as a blank and no protein was placed in 
these wells. Excess liquid was discarded and the plate washed 
twice with PBS/0.05% Tween (200ul/well) before blocking with 
10% Marvel (dried milk protein) in PBS/Tween (150ul/well) for 
Ih at 37®C. Diluted primary antibody was incubated, followed 
by phosphatase-conj ugated second antibody and phosphatase 
substrate, as described in Part 2.2.3b. The colour was
allowed to develop for 30min before reading the plate directly
on an ELISA reader. An O.D. three times higher than
background was taken as positive.
I
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The method as described in Part 2.2.4 was followed but 
instead of using cells, 1ml of protein solution (lOOug/ml) was 
vortexed with 1ml FCA. Purification of the antibodies was as 
described in Part 2.2.5.
0 .5ml solution of protein in PBS (lOOug/ml) was vortexed 
with 0.5ml FCA as described by Coding (1986). A dose of 200ul 
of the mixture was injected into each of the peritoneum of 5 
Balb/c mice. After a few months, a tail bleed was taken from 
each mouse and the serum tested on an ELISA system (see Part 
2.2.5b) for an O.D. three times greater than background. The 
mice were each reboosted with 400ul of protein solution 
vortexed with a 1:1 ratio of Freund’s incomplete adjuvant 
(FIA). Concurrently the myeloma cell line JKAgS was grown up 
in 75cm'"' flasks (Sterilin) in RPMI 1640 medium with 10% FCS, 
glutamine (2mM), benzyl penicillin (50IU/100ml), streptomycin 
sulphate (50ug/100ml), 2-Me (50ul/100ml) and sodium pyruvate 
(ImM) . This medium will be referred to as complete RPMI. 
Mouse peritoneal cell feeder layers were also prepared in ten 
96-well plates (Nunc). This was done by washing out the 
peritoneal cavity of a dead mouse with 1ml cold serum-free 
RPMI medium. The harvested cells were seeded at 2x10^ 
ce 1ls/0.2ml RPMI medium. When a sufficient number of JKAgS 
cells (5x10^ - 1x10®) were obtained, the next procedure was
carried out.
A spleen from an immunised mouse was removed surgically
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under asceptic conditions and teased through a fine mesh in a 
Swinnex holder to obtain a single cell suspension. The spleen 
and myeloma cells were both washed with serum-free RPMI medium 
(SF-RPMI), counted on a haemocytometer and adjusted to give a 
ratio of 2:1 of spleen:myeloma cells. These cells were mixed 
in a universal and centrifuged for 3min at 240g. Concurrently 
1ml of SF-RPMI was added to 1ml of sterile polyethylene glycol 
(PEG, Mr 6kD) which had been pre-warmed to 40®C. .The 
PEG/medium solution (1ml) was then added slowly to the cell 
pellet over a period of Imin. The cell suspension was stirred 
for 90 seconds and then 1ml SF-RPMI was added to the 
suspension, stirring for a further minute. This latter step 
was repeated for 60sec and then again for 30sec. Finally 20ml 
SF-RPMI was added over 2min. The cell suspension was left 
standing for 5min at 37^0 to standardize conditions and then 
centrifuged for 4min at 240g. The supernatant was aspirated 
off and the cells resuspended in 50ml HAT medium (complete 
RPMI containing hypoxanthine (1.36xl0"^mg/ml), aminopterin 
(1.76xl0“^mg/ml) and thymidine (3.86xl0”^mg/ml)). Aliquots of 
the cell suspension (50ul) were distributed into each well of 
the ten 96-well plates containing a peritoneal cell feeder 
layer. After a week the cells were fed with fresh HAT medium 
and about a month later HT medium containing hypoxanthine 
(1.36xl0'""^mg/ml) and thymidine (3.876xl0“^mg/ml) was 
substituted for HAT. The medium was permanently changed to 
complete RPMI after a few more weeks. Appendix 2 shows the 
metabolic pathways involved in the selection of hybridoma 
cells in HAT medium.
I l l
Once the cells were stable in complete RPMI, an ELISA 
test was carried out. Positive colonies were transferred to a 
24-well plate. As soon as the cells were confluent the cells 
were cloned by dilution in which each lOOul of cell suspension 
from a confluent well of a 24-well plate was diluted lOx with 
complete RPMI. 1ml of each suspension was further diluted 
with 10ml medium and then finally lOOul was diluted with 20mls 
with complete RPMI containing catalase (500IU/ml). This 
method enabled each lOOul of cell suspension/well to contain 3 
cells/ml. Samples of lOOul were plated out into 96-well 
plates. After 2 weeks the antibody in the wells was tested on 
an ELISA system. Those cells showing a positive staining for 
the antigen were transferred into a 24-well plate and fed
regularly. On reaching confluence, the supernatant was tested 
against a panel of antigens (see Part 3,4.3, TABLE 5) . The
rest of the cells were grown in mass culture in 200cm'- flasks. 
The supernatant was collected from the flasks weekly and the 
antibody containing solutions were centrifuged at 240g for 
20min. The clear solutions were then stored at 4*^ 0 until
purified. Fig 16 summarises the protocol used in the
production of hybridoma cells.
Fig 16 shows the production of hybridomas.
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The antibody containing supernatant was concentrated 
against aquacide III (polyethylene glycol, Behring 
Diagnostics) until reduced lOx. followed by overnight dialysis 
against PBS.
The method described by Goding (1986) was used as 
follows: A 10ml immobilised protein A column (Biorad) was
equilibrated with phosphate buffer pHS.O. (See Appendix 1) . 
Prepared antibody (10ml) was loaded onto the column using a 
flow rate of 0.5ml/min. Unbound material was washed off with 
phosphate buffer and bound material was eluted succesively 
with citrate buffer pH6.0; 4.5 and 3.5 (see Appendix 1). The 
eluate was collected in 1ml fractions via a fraction 
col lector.
The column was washed with citrate buffer pH3.0, 
followed by phosphate buffer pH8.0 with 0.02% (w/v) sodium
azide and then stored in the dark at 4^C until required for 
further use.
The peaks of the fractions were pooled, filtered through 
a nitrocellulose membrane (Millipore HATF 13750, 0.22um pore
size) and stored sterile at 4°C until assayed on a dot blot 
system. Protein concentrations were worked out for antigen 
specific fractions and frozen in 1ml aliquots until required.
A dose response curve was set up with test protein as 
described in Part 3.2.4a. The optimum protein concentration
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was used to test inhibition of adhesion by antibodies. Before 
incubating cells with the filters, additional adhesive binding 
sites on the filters were blocked with 10% BSA for 30min at 
37*C. Diluted antibody (1ml) at varying concentrations was 
then incubated with the filters for 30min at 37® C. The 
filters were washed twice with PBS before incubating with 
cells as described in Part 3.2.4a. (See Fig 17).
A Western blot was blocked with 10% Marvel in PBS/Tween 
Ih at 37®C. The blot was incubated with 20ml of a 1:100 
dilution of purified antibody solution in PBS for 90 min at 
37‘-*C and washed 3x with PBS/Tween before being incubated with 
20ml of phosphatase conjugated second antibody (Sigma) in PBS 
for 2h at 37°C.
The blot was washed 3x with PBS/Tween and the colour 
developed as described in Part 2.2.3a.
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F ig  17 show s th e  p r o to c o l  u se d  in  i n h i b i t i o n
of  c e l l  a t t a c h m e n t .
INHIBITION OF ADHESION
dot blot of protein to test adhesion activity
tdot blot incubated with 
10% BSA for 30min at 37®CIdot blot incubated with diluted antibody for 90min at 37^0I(3IWashed x  with PBScells incubated with dot blot for 90min at 3 7 ^i2mM EDTA treatment for 
2min. Washed with PBS
■iined
. 1
filter sta  and dried
mounted in emulsion oil
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a.J.; EESULIS
Adhesion is thought to be the first step in 
extravasation as observed in the previous chapter. It was 
possible that the endothelial cells might prove to have 
molecules which would promote the adhesion of tumour cells to
the endothelium (Jaffe et aj., 1976; Jaffe and Mosher, 1970;
Sage ,e,t al» 1981; Hatcher ..e.t al» 1986). Therefore proteins
were extracted from the surface of endothelial cell monolayers 
(CE) and from the conditioned medium (OEM) . The extracted 
molecules were tested for adhesion-promoting activity of 
B16F10 cells.
A dot blot assay was developed whereby proteins to be 
tested for adhesion promoting ability were dotted onto 
nitrocellulose discs. Fibronectin and laminin were used as 
positive controls as they are known to promote adhesion
(Yamada ,e„t ,«1» 1985) . Cells were applied to the filter and
after aan incubation period of 90mins the cells which had not 
attached to the filter were washed off using EDTA treatment. 
Using this assay, adhesion to Fn by the B16F10 cells was 
detectable down to 0.5ng; tp Lm down to 50ng; to CE down to 
300ng; and to CEM down to 400ng. In comparison FCS and cell- 
free controls, at a wide range of concentrations, did not 
promote adhesion.
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In order to confirm that the molecules extracted from 
the endothelial cells promoted adhesion, polyclonal antibodies 
were raised against the extracted endothelial cell surface 
molecules (anti-BAE EXT) and used to block adhesion of the 
B16F10 cells to CE and CEM.
A 1:100 dilution of anti-BAE EXT (3.2mg/ml) blocked 
adhesion to CE (0.7ug) and to CEM (40ug) . This confirms that 
CE and CEM promote adhesion. (See TABLE 4).
The next step was to test anti-BAE EXT in a dot blot 
immunoprobing assay to see if this antibody would cross react 
with other proteins known to promote adhesion. The antibody 
was tested for cross-reactivity to Fn and Lm. The results are 
shown in TABLE 2. BAE cells were not used since they caused a 
positive reaction with the conjugated antibody (due to their 
alkaline phosphatase activity - see Part 2.4.1).
TMLE_„2„.....sM¥.s.......t.b,e .re.lat.iye cros.s„ .r.!g„a.G.t..i.Y..i..t.y of ft.n.t.,l.~BAS E.X.X
icf.iwt.ih .
Antibody Fn Lm CE CEM
0.5ug O.Sug 0.7ug 40ug
anti-BAE EXT 2+ 34- 14- 14-
5+ is the highest score achieved when the conjugated 
second antibody is developed with its substrate.
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These results seemed to indicate that fibronectin and 
laminin were the active molecules in either or both the cell 
extracts. Therefore it was decided to test antibodies raised 
against Fn and Lm to see if they cross-reacted with and/or 
blocked adhesion to CE and CEM. Other antibodies were also 
tested and included anti-S protein, anti-thrombospondin and 
anti-anti thrombin III. The results are summarised in TABLES 
3 and 4.
MQnoc.,.lona,,l antibodies
Antibodies were raised and purified against Fn as 
described in Parts 3.2.7 and 3.2.8. 1:100 dilutions of anti-
Fnl (250ug/ml) and anti-Fn2 (1390ug/ml) were tested against Fn 
(O.Sug), Lm (O.Sug), CE (0.7ug) and CEM (40ug) in either 
immunodot blot/ELISAs and in adhesion blocking assays. (See 
TABLES 3 and 4).
The source of these antibodies was as follows: The
anti-endothelial cells extract (a-BAE EXT) was raised in 
rabbits and purified as described in Parts 2.2.4. The anti- 
fibronectin (a-FN) and anti-anti thrombin III (a-ATIII) were 
raised in sheep and obtained from the Scottish antibody 
production unit, Carluke. The anti-S protein (a-SP) obtained 
from Calbiochem. anti-laminin (a-LM) obtained from 
Collaborative Research and anti-thrombospondin (a-TSP)
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obtained from Dr N. Hunter, Scottish Blood Transfusion Centre, 
Edinburgh, were raised in rabbits.
Dilutions of antibody (1:100) - a-BAE EXT (3.2mg/ml), a- 
FN (18mg/ml), a-ATIII (18mg/ml), a-SP (Img/ml), a-TSP (Img/ml) 
and a-LM (Img/ml) were tested against Fn (O.Sug), Lm (O.Sug), 
CE (0.7ug) and CEM (40ug) in immunodot blot/ELISa and in 
adhesion blocking assays. (See TABLES 3 and 4).
iaE.LE....a._...IesJ; p.c.if
Antibody Fn0.5ug
Lm
0.5ug
CE
0.7
CEM
40ug
a-FNl (m) 3+ - - -
a-FN2 (m) 24- - - -
-?-BAE EXT (p) 24- 34- 14* 14-
^-FN (p) 54- 14- - -
a-ATin (p) - - - 34-
-^SP (p) - - - 24-
Æ-LM (p) - 54- 14- -
;î-TSP (p ) - - - -
5+ Is the highest score and is achieved when
conjugated second antibody is developed with its substrate.
p=polyclonal antibody 
m=monoclonal antibody
J
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The results from TABLE 3 indicate that CE contains 
laminin and CEM contains anti thrombin III and S-protein. 
These results are in agreement with those of Martin and Timpl, 
1987; Owens and Miller, 1980; Preissner  al, 1988.
TABLE 4,..,.shows the„...re..latiye crpss r.e..m.G.t..lyitY  some .antibodlsa.
Antibody cell extract cell extract medium
adhesion adhesion
^’-FNl (m) (5+) (3+)
Æ-FN2 (m) (5+) (2+)
^-BAE Ext (p) (4+) (2+)
^ F N (p ) (5+) (4+)
^-ATIII (p) (5+) (2+)
^-SP (p) (5+) (5+)
a-L M  (p) (4+) (5+)
^-TSP (p) (5+) (5+)
The results from TABLE 4 indicate that CE contains 
laminin and CEM contains fibronectin and anti thrombin III. 
These results are in agreement with those of MArtin and Timpl, 
1987; Owens and Miller. 1980; Hatcher <9..t a 1, 1986.
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In order to determine if the adhesion promoting 
molecules extracted from endothelial cells were known 
molecules such as fibronectin. laminin or vitronectin, protein 
characterisation using SDS-PAGE and immunoprobing of Western 
blots was carried out.
The band patterns are shown in Photograph 12; the
percentage concentration of each protein component was
estimated from scanning densitometer traces.
 e..x.tr.,a.c..t..s ..(..C.E..,„..a.o.d .CEM),..
CE is a complex mixture of proteins containing more than 
11 resolvable bands under reduced conditions (TRACKS 4 and 8).
CEM showed 9 resolvable bands under reduced conditions 
and 6 resolvable bands under non-reduced conditions (TRACKS 5 
and 9).
.1^.
Fibronectin (Fn) is a large glycoprotein of about 440kD 
and is present as a dimer (220kD and 210kD) (Yamada and Olden, 
1978). Using SDS-PAGE analysis there were 9 resolvable bands 
under reduced conditions and 12 resolvable bands under non­
reduced conditions (TRACKS 2 and 6) . The 440kD, 220kD and
210kD components comprised 65.5% of the total protein analysed 
under non-reduced conditions. The smaller Mr bands (35.5%) 
seen in Photograph 12 are probably fragments of Fn or serum 
protein contaminants.
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.ç.). Lam,i.a.in
Laminin (Lm) is a large flycoprotein of about lOOkD 
which consists of three 200kD chains and one 400kD chain 
(Kleinman «.Lai, 1984) . In this analysis, Lm appeared to have 
4 resolvable bands under reduced conditions and 3 resolvable 
bands plus a precipitate at the origin under non-reduced 
conditions (TRACKS 3 and 7) . The lOOOkD component is seen as 
a precipitate at the origin and the 200kD and 400kD components 
comprise 92% of the total protein content under reduced 
conditions. The smaller Mr bands (8%) seen in this sample may 
be fragments of Lm (Photograph 12).
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P.h.o.t_og.rap.h......l.2 shows the protein bands for Fn. Lm. CE and CEM
Lanes 1. 6. SD8-2._Mr.._mar^ myosin (205kD) , B
galactosidase (116kD). phospholipase (97.7kD). BSA 
(66kD). egg albumin (45kD) and carbonic anhydrase 
(29kD) .
Lane 2. Ea..Xfad.U.C,ed (20ug) 440kD, 220kD, 210kD. 200kD
ISOkD, 142kD. 120kD. 89kD. 56kD and at front.
Lane 3. Lm..X3Û\X.Q3Û (20ug) 400kD. 200kD, 120kD and llOkD.
Lane 4. CE.„.,Od.UC..S.d (30ug) 330kD, 300kD, 186kD. 116kD,
103kD. 94kD. 66kD-56kD. 43kD.37kD and at front.
Lane 5. CEM...XSdU.C..e,d (160ug) 330kD. 300kD, 179kD. 140kD,
116kD, 105kD. 95kD. 75-63kD. 49kD. 43kD and at front. 
Lane 7. F.a„.n.Q.n=.r.ed.u.c?..ft.d (20ug) at origin, 440kD. 220kD.
210kD. 193kD. 187kD. 175kD. 135kD, 113kD, 77kD, 60kD. 
54kD and at front.
Lane 8. Im„..n.Q.n-r.ad.u.c..©d (20ug) at origin, 400kD, 193kD and
107kD.
Lane 9. C.Kx.Q.n.X.!Sd.UC.M (30ug) 440kD, lOSkD, 61kD, 54kD, 
50kD and at front.
Lane 10. .CEK.,.D.an-.r.e.du.G.e.d (16Dug) 600kD, 400kD, 155kD.
107kD. 63kD“53kD and at front.
_  ro >o —* oNI O  Cn
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When comparing the cell extracts (CE and CEM) with each 
other it was found that CE contained an exclusive band at 37kD 
(reduced). CE lacked components at 179kD and 140kD (reduced) 
and 155kD (non-reduced) which were found in CEM. Some of the 
components had similar electrophoretic mobilities to those 
found in CE. Although comparison was made with cell free 
controls and fetal calf serum. it was not possible to 
determine whether these proteins were derived from the 
endothelial cells or the serum used in the medium. In the 
cell derived extracts and cell free controls, the major 
component (between 65-80%) was observed with mobilities around 
70kD-60kD (reduced) and 65kD-55kD (non-reduced). This 
component ran with similar electrophoretic mobilities to 
bovine serum albumin.
When comparing CE and CEM with laminin and fibronectin. 
it was not possible to identify the Fn and Lm components in 
the extracts, which had been indicated by immunodot blot 
analysis (see TABLE 3).
Although CE and CEM were shown to promote cell 
attachment, from this SDS-PAGE analysis it was not possible to 
say which band(s) caused it nor whether the various bands are 
Fn, Lm, Vn. fragments of these proteins or a novel protein. 
It had been hoped that probing Western blots of SDS- 
polyacrylamide gels would be a useful tool in identifying the 
actual molecular masses of the adhesion-promoting components, 
but this proved to be unsuccessful. (See Appendix 3).
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In order to try and work out the Mr of the cross­
reacting components, Western blotting analysis was carried out 
instead. In most cases the antibody sensitivity resulted in 
the detection of smears rather than specific bands.
The antibodies which cross reacted with Fn (see TABLE 
3), commonly immunoprecipitated an 187kD (non-reduced 
conditions) and 52kD (reduced conditions) band.
The antibodies which cross reacted with Lm, commonly 
immunoprecipitated a 440kD (non-reduced conditions) band.
The antibodies which cross reacted with CE, commonly 
immunoprecipitated a 37kD band (reduced conditions).
Out of the antibodies which cross reacted with CEM. 
anti-BAE EXT immunoprecipitated bands at 187kD (non-reduced 
conditions) and 52kD (reduced conditions), anti-S protein and 
anti-ATIII immunoprecipitated two bands at 250kD and 105kD 
(under non-reduced conditions). This latter result suggests 
that S protein and anti thrombin III in CEM are complexed 
together under non-reduced conditions. However, under reduced 
conditions they become denatured and so fail to interact with 
these antibodies.
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In the dot blot adhesion assay developed in this study, 
the extracted endothelial cell proteins (CE and CEM) were 
found to promote, adhesion to varying degrees, but not to as 
great an extent as Fn and Lm.
In order to confirm that CE and CEM do promote adhesion, 
a polyclonal antibody raised against endothelial cell surface 
proteins (anti-BAE EXT) was used to try and inhibit adhesion. 
Using this analysis, it was found that this antibody did 
indeed block B16F10 cells from adhering to CE and CEM (the 
latter being inhibited to a greater degree).
On further analysis with this antibody, it was found to 
cross-react with Fn and Lm. It was therefore decided to test 
antibodies raised against Fn and Lm, as well as those against 
vitronectin, thrombospondin and anti thrombin III to see if 
they would cross react with either CE and CEM and also to test 
them in inhibiting adhesion. It was found that although the
Fn antibodies did not appear to cross react with either CE or 
CEM, they blocked adhesion to CEM. The anti-FN may not cross 
react with CEM for a variety of reasons, one of which might be 
that fibronectin in CEM may not be detectable by immunological 
methods but may by adhesion-promoting activity (Ferro et al, 
1988). Anti-LM cross reacted with, and slightly blocked 
adhesion to CE, while anti-anti thrombin III cross reacted
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with and blodked adhesion to CEM. On the other hand, anti-S 
protein cross reacted with, but did not block adhesion to CEM. 
This apparently contradictory result is not easily explained. 
It is likely that a complex of S-protein and anti-thrombin III
is contained in CEM. It might be that the antibodies in the
polyclonal anti-SP are able to react with some epitopes of S- 
protein, but not with the cel 1-adhesion promoting epitopes. 
Alternatively, this may be a function of the different 
configurations taken up by the molecule on plastic or 
nitrocellulose. Anti-TSP did not cross react or block 
adhesion to either CE or CEM. Although thrombospondin is
synthesized by the endothelial cells, it is produced in very 
small quantities and this may explain these results (Raugi et 
ai.., 1982) .
In order to determine which components of the extracts 
were cross reacting. Western blotting analysis was carried 
out. This analysis revealed that the cross reaction of anti- 
LM with CE could not be detected, possibly due to the
conditions of electroblotting and electrophoresis denaturing 
the cross reacting moiety. However, a 37kD Mr component 
(reduced) of CE was detected by anti-BAE EXT.
On the other hand, CEM cross reacted with anti-SP and 
anti-ATIII at the same positions (205kD and lOSkD) and this 
showed that the two proteins were probably associated with 
each other as described by 111 and Ruoslahti, (1985).
Preissner ,e„t ûl (1988) indicated that this Vn/ATI 11/thrombin
complex has a molecular mass of 350kD as worked out by SDS-
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PAGE analysis. In addition to Vn, there may also have been Fn 
present since anti-BAE EXT cross reacted with an 187kD band 
(thought to be an Fn fragment). Turther evidence for this was 
that the anti-fibronectin monoclonal antibodies prevented cell 
adhesion. It would therefore appear that adhesion by CEM is 
promoted by an anti thrombin III/ thrombin/Vn complex and by 
Fn.
3,...4„.„2 SDS p.Q,.ly.acryi,.amide g.e.l„„ .ao,alY.S.i..s.  .Q.f. CE and.
CEM
Characterisation of the molecules extracted in this 
study was achieved by SDS-PAGE. The results showed that CE 
and CEM contained a mixture of proteins. CE had an exclusive 
band at 37kD (under reduced conditions) and lacked components 
155kD (non-reduced conditions), 140kD and 179kD (reduced
conditions), found in CEM.
Comparison was also made with Fn and Lm, but this did 
not reveal any similarities. The pitfalls involved in making 
comparison using gel electrophoresis should be borne in mind. 
Although most soluble peptides migrate linearly according to 
the logarithm of their molecular weights (Weber and Osborn, 
1969) it is not certain that this is true for extremely 
hydrophobic polypeptides or all glycoproteins. Therefore all 
molecular masses determined for surface or membrane proteins 
should be considered as nominal only. Furthermore, the values 
obtained depend on the exact conditions of the electrophoretic
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analysis, degree and nature of cross-linking of the gels and 
Mr of the standards used. Similarity and/or co-migration or 
Mr do not necessarily indicate identity. One way of resoving 
this problem might be to use isoelectric focussing. 
Alternatively antibody analysis can be used as well, as was 
employed in this study.
When comparison of CE and CEM was made with FCS and cell
free controls, it was difficult to discern which of the
proteins in the extracts were derived from the serum or from 
the endothelial cells themselves. For future experiments, it 
would be better ro radio-label the metabolites used in culture 
by the cells, in order that the cell derived proteins be
detected by radioactivity (Browning .e.t dl, 1983) .
In conclusion, the results seem to indicate that 
adhesion was caused by proteins on the endothelial cell 
surface (a 37kD protein whose identity is not known and 
possibly Lm) and in secretions into the medium (Vn/ATIII and 
Fn) . A 37kD protein has been described in FS9 Sarcoma cells 
which is thought to be involved in metastasis (Steinman 
1984). It will remain to be seen if these two proteins are
the same. One way of doing this would be to use antibodies 
raised in this study (such as anti-BAE EXT) to see if they 
cross-react with the 37kD component described by Steinman e.t 
•
The results of this chapter indicate tha Vn, Fn and Lm
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which are synthesised by endothelial cells, are important in 
promoting adhesion of B16F10 cells. The way that these 
results could fit in with the observations made in Chapter II, 
would be as follows; Adhesion-promoting molecules such as Vn 
and Fn could have been released into the medium (CEM)
(Preissner .§..t .«..I» 1988; Birdwel 1 1978; Hatcher
1986) . The released molecules may then have either become 
adsorbed to the plastic or to the surfaces of the tumour 
cells. This would then enable tumour cell aggregates which 
had detached from the initial seeding areas to attach to the 
monolayer or to the plastic as seen in Part 2.3.2. (See Fig.
18). On the other hand, adhesion promoting molecules on the 
endothelial cells themselves (Lm and possibly 37kD) (Martin 
and Timpl, 1987) would have promoted attachment to the 
monolayer only as these molecules were not released into the 
medium. (See Fig 18).
Now that the identity of the adhesive proteins in these 
extracts have been tentatively established it will be possible 
to purify them using gel filtration and immunoaffinity 
chromatography. For future experiments, I would suggest using 
a monoclonal antibody such as anti-FNl to purify the 187kD 
component in CEM and gel filtration as a further step in the 
purification of the 37kD component in CE. Monoclonal }Jantibodies should be used because they can be screened for IÎ
their ability to interfere with specified cell interactions Jjand can be produced against minor surface components of a 4
132
particular cell type. In contrast to polyclonal antibodies, 
monoclonal antibody preparations are highly specific and can 
be made in unlimited amounts. Furthermore heterogenous 
material (such as whole cells) can be used for initial 
immunization and the relevant antigens subsequently purified 
by immunoaffinity chromatography.
The purified extracts could then be further 
characterised and tested in adhesion assays to confirm that 
they do promote adhesion. Monoclonal antibodies could be 
raised against these components and used in animal models and 
experimental métastasés as have been done by Vollmers and 
Birchmeier, (1983a; 1983b) - this being the ultimate aim of a 
study such as this. Other experiments which could be done, 
would be to test combinations of antibodies to try and totally 
inhibit adhesion. This would show whether these molecules 
work in concert or individually in promoting adhesion.
For future work it would also be of interest to test 
other tumour cell lines and variants of the B16 melanoma 
against these extracts. In addition, extracts from other 
endothelial cell lines could also be tested against to see if 
tumour cells adhesion to endothelial cells is organ-specific
as has been suggested (Alby and Auerbach. 1984; Horak  ai,
1986; Nicolson and Dulski, 1986).
Fig 18 shows possible roles for CEM and CE in promoting substrate adhesion in 
vitro during the extravastion experiment of Part 2.4.
a) shows the BAE cells producing substrate adhesion promoting molecules 
(CEM) which may bind either to the substrate or to the B16F10 cells.
i) The molecules which attach to the plastic substrate may cause B16F10 
cells to attach to the plastic.
ii) The molecules which attach to the cells may cause the B16F10 cells to 
attach to the plastic or
iii) to the endothelial cells.
b) shows the B16F10 cells attaching to cell surface 
proteins on the endothelial cells.
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 I..NTHQ.D.yC.!I!.I.Q.N
During extravasation, adhesion to the endothelium is 
thought to be followed by spreading of tumour cells. 
Spreading increases the surface area of a cell which enables a 
greater interaction with the substrate which presumably 
maintains a stronger hold on the endothelium. Spreading 
requires the extension, attachment and contraction of 
pseudopodia and is thus dependent on activities of the 
cytoskeleton which are regulated by calcium (Lackie, 1986).
Since spreading is, in part, dependent on adhesion it 
seemed pertinent to investigate whether the molecules which 
had promoted adhesion would also promote spreading. It is 
known that various glycoproteins which promote adhesion also 
promote spreading. Some of these have already been considered 
in the previous chapter.
To date, fibronectin is the most studied adhesion- 
promoting glycoprotein which also stimulates cell spreading in
many cells (Yamada .at. al, 1985) . Among the effects of Fn on
transformed cells, the cells generally lack we 11-organized 
microfilament bundles but on addition of Fn. microfilament 
bundles are restored (Ali and Hynes, 1977). This effect could 
reflect increased spreading, but it seems probable that it
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reflects a more direct effect of Fn on the cytoskeleton.
Cellular Fn is thought to mediate attachment in close
association with the cytoskeletal elements. Support for this 
has come from various observations. To correlate the 
organization of actin with Fn, it was necessary to use methods 
which allowed visualisation of both actin and Fn at the same 
time in the cell. This was accomplished by double label 
immunofluoresence. While these studies showed a high degree 
of correspondence between Fn and actin, an obvious drawback is 
that they are limited by the resolution of light microscopy 
(0.2um). Higher resolution was achieved by Singer (1979)
using electron microscopy. He showed that bundles of Fn 
fibrils outside the cell were apparently continuous with 
microfilament bundles inside the cell. Further information
was achieved using reflection interference microscopy (Avnur 
and Geiger, 1981). In this technique, the thin film of medium 
between the base of the cell and the substratum is exploited 
as an interference film and the intensity of the reflection of 
monochromatic light, or less often, the colour of the 
reflection of whole light provides information about the 
thickness of the film. Areas of very close contact (eg 
attachment plaques) produce strong negative interference in 
monochromatic light and appear dark. Use of this technique, 
in combination with electron microscopy, established that 
attachment plaques are points of termination of actin 
microfilament bundles. Other experiments (Chen et ai. 1980)
showed Fn to be found adjacent to focal adhesion sites in the
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close contact sites and so it is possible for coordination of 
adhesion and spreading to occur by the transmembrane linkage 
of Fn with actin.
There is also thought to be some sort of transmembrane 
linkage between the focal contact sites (as opposed to the 
close contact sites) and the intracellular microfilaments. 
For some time vinculin was thought to play this part, mainly 
because it was enriched in this area and because it was 
thought to interact diretly with actin. The latter has since 
been shown to be untrue (Wilkins and Lin, 1986). Furthermore, 
vinculin was the first adhesion plaque protein found to 
contain elevated (8x) phosphotyrosine levels in cells
transformed by Rous sarcoma virus (Selton e..t .a.1, 1981) . This
result, combined with localization of the RSV oncogene product 
pp60‘““"‘" within adhesion plaques (Rohrschneider, 1980) , led to 
the proposal that phosphorylation of vinculin is a major event 
in the disruption of adhesion plaques in transformed cells. 
This model has not been supported by subsequent work (Kellie
,e.t a 1, 1985) . Weigant et al (1986) suggested that vinculin
phosphorylation has little significance in the coordination of 
adhesion and spreading, since the level of vinculin 
phosphorylation is low at best and is a coincidental event 
reflecting its proximity to the oncogene product pp60*^=. 
Recently, talin (another adhesion plaque protein) has also been 
found to contain phosphotyrosine and to have elevated levels 
in cells transformed by RSV (De Clie and Martin, 1987). But 
as in the case of vinculin, it does not correlate with loss of
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stress fibres or rounded morphology. Other possible cellular 
substrates of P60^-*rc that are phosphorylated on tyrosine
which are relevant to this study are the Fn receptor, the 
avian fibroblast integrin receptor and calmodulin (Hirst at 
ai, 1986) .
As yet there is much controversy in this subject area and 
it is difficult to envisage how all the effects of ECM 
molecules can be mediated via a simple transmembrane linkage 
to cytoskeletal components.
Laminin induces spreading in some cells (Terranova,
1980). Since the RGD peptide in its free form inhibits cell
spreading (Ruosalahti, 1988a), it is likely that spreading is
mediated via an RGD peptide. This would indicate that 
spreading and adhesion to Lm are related. However it may be 
that the 68kD Lm receptor to the CDGYPSIR site, which also 
binds specifically (Kd 6x10*"^ ) to actin filaments (Brown at 
al, 1983), may connect the intracellular cytoskeleton to the 
extracellular matrix and influence cell shape (Cody and Wicha, 
1986) .
.4„,,...i„.,..,3„....Qther„ giy.c..Qpr.Q,t..ei.Bs
other molecules which are known to cause spreading and 
adhesion are vitronectin (Yamada, 1983), vWF (Santoro, 1987)
and thrombospondin (Varani at S.1, 1986) . However, tenascin
has been shown not to promote spreading (Chiquet-Ehrismann at. 
al, 1‘988) .
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Since the spreading phenomenon is of potential importance
in haematogenic metastasis, many In 0...tr.fi assays have been
developed to investigate the properties of spreading. Since 
spreading is, in part dependent on adhesion it seemed 
pertinent to investigate whether the molecules which had 
promoted adhesion, would also promote spreading.
One method of investigating spreading molecules depends 
on the binding characteristics of putative molecules to a 
variety of substrates - in particular to tissue culture-grade 
plastic (Yamada, 1983). In these experiments, test proteins 
were bound to culture-grade petri dishes and seeded with 
tumour cells. Light microscopy was used to give a direct 
measurement of the spreading-promoting activity of the test 
molecule. I took these experiments one step further by 
measuring the mean surface area of cells spread on numerous 
test molecules. This substrate also proves useful for testing 
inhibitors of spreading, such as antibodies directed against 
the spreading molecules or against the cell surface. 
Therefore the aim of this part of the thesis was to see if the 
adhesion molecules extracted from BAE cells could also promote 
spreading of B16F10 cells. This together with the use of the 
antibodies used in the previous chapter would give some 
indication of whether the processes of adhesion and spreading 
are related.
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4..,,.2,....MATERIALS AND. METHODS.
lOOul of sterile protein solution in PBS. at a wide range 
of dilutions, was incubated in a tissue culture grade 96-well 
flat bottomed plate (Nunc) for 2h at 37*^ 0. Excess protein 
solution was aspirated off and additional binding sites on the 
plate were blocked with sterile 1% BSA in PBS for Ih at 37^C.
B16F1Ü cells were harvested as usual and resuspended in 
serum free EC medium with 1% BSA to a final concentration of 
4x10^ cells/ml. lODul of cell suspension was added to each 
well. The percentage of spread cells to total number of cells 
was determined in one field of view at x20 objective lens 
magnification at 30 min and 60 min (See Fig 19).
Photographs were taken of cells spread after 3h on 
protein, dotted onto tissue culture-grade petri dishes. This 
time was chosen in order to achieve maximum spread for all the 
proteins. In order to quantify spreading, the surface area of 
the spread cells was determined for each protein using a 
computer programme written by Mr K Thom in the Department of 
Biology and Preclinical Medicine. St Andrews. This involved 
tracing 10 cells onto a digitized pad and the computer 
calculated the mean surface areas from this data.
A dose-response curve was set up for each test protein. 
The optimum protein concentration which promoted spreading was
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used when inhibition of spreading by antibodies was being 
tested. The method followed was as for Part 4.2.1, but prior 
to cell incubation, a lOOul dilution of antibody was incubated 
in each well at 37®C for 30 min. The antibody was washed out 
with PBS before adding the cells. (See Fig 19).
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Fig 19 shows the protocol used in spreading and inhibition of 
spreading
SPREADING AND INHIBITION OF SPREADING
protein solution incubatecL in 96-well plate for 2hr at 37^CIplate blocked wifh« 
1% B SA forlhr at 37^0
cells incubated in plate at 37^0 for 30min and 60min
tspread cells counted
antibody 
incubated for 30rains 
at 37%
plate washed x2 with PBS
143
4..3 RESULIS
A comparison was made of the spreading activities of the 
B16F10 cells on the extracts obtained from endothelial cell 
monolayers, which had been shown to promote adhesion in the 
previous chapter. A spread morphology was defined as a cell 
where the nucleus was clearly visible and where the cell 
either possessed a thin, well-spread cytoplasm or had mor than 
three cytoplasmic extensions. The spreading responses are 
shown in TABLES 5-7.
The spreading response to BAE cell surface extract (CE) 
was 34% and 80% at 700ug/ml after 30min and 60min 
respectively. On conditioned medium of the BAE cells (GEM) 
the spreading responses were 40% and 70% at 4mg/ml after 30min 
and 60min respectively.
In comparison, the controls Fn and Lm promoted greater 
spreading. On Fn a peak response of 80% at 40ug/ml after 
30min and 86% after 60min was achieved. On Lm a peak response 
of 85% at 30ug/ml after 30min and 98% after 60min was 
achieved. On fetal calf serum (FCS) 19% of the tumour cells 
spread at 4mg/ml after 30min. This value increased to 78% 
after 60min. The cell-free extracts showed little, if any 
tumour cell spread-promoting ability. These differences in 
concentration are due to the extracts not being pure. If the 
active components are purified, the peak responses would 
probably be at concentrations similar to those for Fn and Lm.
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Under the light microscope the morphologies appeared to 
vary although it was noted that all the extracts met with the 
criteria for a spread morphology.
Photographs 13-18 show the spread morphologies of tumour 
cells after 3h incubation (in order to obtain maximum spread 
of cells), using light microscopy.
n=4
CE conc %  spread ±S.D.
0.07ug/ml 0.0 ± 0.0
0.7ug/ml 0.0 ±  0.0
7.0ug/ml 0.0 ± 0.0
70ug/ml 0.0 ± 0.0
700ug/ml 34.0 ± 2.1
CEM conc % spread ±S.D.
4ug/ml 0.0 ± 0.0
40ug/ml 0.0 ± 0.0
400ug/ml 15.0 ±  1.2
4mg/ml 34.2 ±  3.1
40mg/ml 40.0 ± 2.2
Photograph 13
Shows the spread morphologies of B16 cells on 700ug/ml CE 
after 3 hours. Magnification x270.
Photograph 14
Shows the spread morphologies of B16 cells on 4000ug/ml CEM 
after 3 hours. Magnification x280.

n=4
Fn conc %  spread ±S.D.
lOug/ml 55.4 ± 2.1
20ug/ml 63.7 ± 6.1
30ug/ml 70.3 ± 2.6
40ug/ml 80.2 ± 3.0
50ug/ml 69.5 ± 2.4
Lm conc %  spread ±S.D.
lOug/ral 57.2 ± 1.0
20ug/ml 80.4 ± 2.4
30ug/ml 85.8 ± 1.3
40ug/ml 78.1 ± 4.8
50ug/ml 74.4 i 3.2
TABLE shows the %  number of spread cells for FCS
after 30min.
n=4
FCS conc % spread 
± S.D.
4ug/ml 12.4 ± 1.3
40ug/ml 14.2 ±  2.4
400ug/ml 12.1 ± 6.2
4mg/ml 19.5 ±  4.8
40mg/ml 10.3 ± 3.2
Photograph 15
Shows the well spread morphologies of B16 cells on 40ug/ml Fn 
after 3 hours. Magnification x550.
Photograph 16
Shows the spread morphologies of B16 cells on 40ug/ml Fn 
after 3 hours. Magnification x270.

Photograph 17
Shows the spreading morphologies of B16 cells on 30ug/ml Lm 
after 3 hours. Magnification x270.
Photograph 18
Shows the spread morphologies of B16 cells on 4000ug/ml FCS 
after 3 hours. Magnification x270.
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Quantification of the surface areas of the spread cells 
was made from photographs of the spread cells. The results 
are as follows.
TABLE 8 shows the surface areas of spread cells on various 
proteins
n-10 number of spread cells
Proteinconc. Mean Surf^e Area um -  S.D.
% unspread 
±  S.D.
Fn 40ug/ml 884.7 ± 236.5 11.5 ±  3.2
Lm 30ug/ml 1018.4 ±  362.7 5.3 ±  0.2
CEM 4000ug/ml 875.5 ± 116.1 16.1 ±  1.5
CE700ug/ml 989.5 ± 248.7 13.0 ±  2.1
FCS 4mg/ml 510.4 ±  115.5 20.2 ±  0.5
The results indicate that there is little difference in 
the surface areas occupied by cells spread on Fn, Lm, CE and 
CEM. However, from t-tests, FCS is significantly different 
from Fn (t-2.93, p-0.013), Lm (t-3.15, p-0.0092), CEM (t-4.15, 
P-0.0013) and CE (t-4.15, p-0.0013).
The optimum protein concentration used for testing 
inhibition of spreading by antibodies, was obtained from the 
dose-response curves set up in Part 4.3.1a.
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a.) .EncLo.the.l ..i.a.l .c..0_l..l 0 x t r act.
None of the tested antibodies showed any inhibition of 
spreading to CE.
b ). .C.o.n,d.i..t..i.o n0d me d.i.,um .e.ix.t.r .a.ci..t .C.C.ENI.)..
The antibodies which showed a significant inhibition to 
40mg/ml CEM were anti-FNl (2.5ug/ml), anti-FN2 (14ug/ml), 
anti-Fn (18mg/ml). anti-BAE EXT (3.2mg/ml) and anti-ATIII 
(1.8mg/ml). The F ratios (as determined by analysis of 
variance) are indicated in Fig 20. TABLE 9 and Fig 20 show a 
summary of the responses of the tested antibodies.
TABLE ?  shows the effect of active antibodies in inhibiting cell spread to CEM
n=4
%  number of spread cells ±  SD
antibody neat 1:10 l l t f 11(P 1104
,7-FNI (m) 
(250ug/ml) 10.1± 1 .0
10.2
± 1 3 18.5±3.2
23.4
± 4 .2 40.0±5.1
,?-FN2 (m) 
(650ug/ml) % . l
13.2
±2.3
27.4 . 
±5.1
^ .7  
± 5.3
,?-BAE EXT (p) (3.2mg/ml) 27.6 ± 2.3 30.8 ± 4.1
38.4
± 3 .2 50.1 ± 5.3 40.1 ± 1.3
^-FN (p) 
(%8mg/ml) 25.1±3.1
44.6 
± 2.5
39.2
±4.1 41.6 ‘ ± 2.4
39.9
± 4 .5
,y-ATIII (p) 
(17mg/ml) 0,0±0 .0
15.1 
± 2.6
30.3
±7.1 # 1±5.3
40.1
± 4 .7
^-SP (p) (Img/ml) 38.2 + 4.2 39.3 ± 3.8 36.1 ± 4.1 37.5 ± 3.2 38.2± 3 .2
â-U s/i (p) (Img/ml) 39.1 + 2.3 39.0± 2 .6 37.3±3.4 38.5 ± 4.1 7 40.1±3 .5
The neat concentration of the antibodies is shown in brackets.
Fig 20  shows the effect of a) anti-FNl (m), b) anti-FN2 (m),
c) anti-ATIII (p), d) anti-BAE EXT (p) and anti-FN (p) on the 
spreading response of B16F10 cells on CEM (40mg/lml).
S.D. is as shown on TABLE ^ .
% Spread cells
40
30 H
neat 1:10 1:100 1:1000 1:10000
AB dilution
n-4
: i  CONTROL
-o- anti-Fnl (f=431.i, (df:i,20))
-*■ antl-Fn2 (f=2B9 .7, (df:i,20>) 
anti-anti Till (f=i67.2, (df:i,20)) 
-A- anti-BAE Ext (F=40.8, (df:l,20)) 
anti-Fn(p=41.2, (df:i,20))
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4.,„.4 M.aQy.eSJ..QM
It was observed in Chapter II that following adhesion to 
the endothelium, the B16F10 cells spread on the substrate. 
Morphological changes also occurred in the tumour and 
endothelial cells during their interaction with each other,
which have been previously discussed. It therefore appears
that adhesion and spreading of tumour cells onto the vascular
endothelium are important processes which occur during 
extravasation. Kramer and Nicolson (1979), suggested that 
molecules present in serum and on the endothelial cells may 
have a role to play in promoting the spreading of 
metastasising tumour cells onto the vascular endothelium as 
they did in adhesion.
From the results obtained in Chapter III, it was 
established that adhesion of tumour cells was promoted by
molecules from the endothelium.
The spreading assay used in this study indicated that 
both CE and CEM promoted spreading of the B16F10 cells. In 
contrast, the controls (FCS and CFE) promoted little 
spreading. Analysis of the surface areas covered by the cells 
on the various extracts revealed that on the spreading- 
promoting substrates the surface areas were very similar and 
in contrast to those on the inactive substrates. This 
therefore appears to be a more satisfactory means for 
measuring spreading promoting properties of a molecule than 
just by looking at the morphology of the cells.
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  Ir)omuno.i.Qs.l.c.,al_.,...)appr.Q.ach..,,t.o...,„s.pr.e,adl.ng^
Spreading on CE was not inhibited by any of the 
antibodies used in this study. The reasons for this can only 
be speculated at and may be verified by the fact that adhesion 
to CE was only slightly inhibited by anti-BAE EXT and anti-Lm. 
For future work it would be interesting to see if both these
antibodies together would inhibit spreading.
Spreading to CEM was significantly inhibited by the 
fibronectin monoclonal antibodies anti-FNl and anti~FN2 and 
polyclonal antibodies anti-Fn, anti BAE-EXT and anti-ATIII. 
These are the same antibodies which inhibited adhesion. Also 
from previous analysis it may be presumed that these
antibodies are reacting with Fn (187kD fragment) and an
ATI II/thrombin/Vn complex. This indicates that spreading is 
dependent on the same molecules in spreading and adhesion on 
CEM. From this comes the suggestion that spreading is an 
extension of adhesion and not an independent process. It will 
remain to be seen if control of these two processes is also 
the same.
.4,..#...4,.*.,.2 1^0-0
It would appear from the results obtained in this chapter 
that CEM promotes spreading of B16F10 cells by an 187kD 
fragment of Fn and a Vn/ATI 11/thrombin complex. For CE it is 
not possible to deduce the spreading moiety since none of the 
antibodies inhibited it. Therefore it can be seen that it is 
likely that endothelial cell proteins play an important role
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in inducing spreading of the tumour cells and may do so 
through molecules such as Fn and Vn. However, there may be 
other molecules invoved, since spreading to CE could not be 
inhibited.
The way in which these results fit in with the
observations made in Chapter II are as follows: In. vJ±r.Q
molecules such as Fn, Vn and ATI 11 released by the BAE cells
into the culture medium (CEM) (Hatcher e.t_ .a.1, 1986; Preissner
.e„.t aj,, 1988) could attach to the plastic and cause the B16F10
cells to spread on the substrate.
The way in which CE may promote spreading is less clear. 
One possibility is that as the BAE cells retract from the 
tumour cells, they leave behind surface molecules onto which 
the B16F10 cells can spread. This could explain why prior to 
rolling the monolayer, the tumour cells were elongated, but on 
moving underneath the monolayer, the tumour cells appeared to 
be well spread (see Part 2.4.2). An alternative explanation 
would be that the tumour cells are spreading on the 
extrace 1 lualr matrix laid down by the BAE cells (Birdwell e..t. 
ai.., 1978; Kramer and Nicolson, 1982) .

161
S,.»..,l X.NÜ'H.QDXiî.Cü! I.QN.
A natural conclusion to this thesis seemed to be to study 
migration of the tumour cells through the endothelium. Three 
steps leading to. migration were proposed by Liotta (1986):
(1) tumour cells attach to components of the matrix via 
receptors to molecules such as Lm and Fn.
(2) hydrolytic enzymes are secreted - the matrix is degraded, 
including attachment components.
(3) locomotion occurs by pseudopodia 1 extension and 
contraction, and by further attachment to components of the 
matrix. A repetition of these three steps may occur until the 
tumour cell is through the barrier. (See Fig 21 taken from 
Liotta, 1986).
i Lm receptor ^  Lm  -- BM
enzymes
Fig 21 shows the three steps to extravasation.
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After implantation in the microcirculation, blood-borne 
metastatic cells must penetrate the endothelial basal lamina 
in order to extravasate: thus it is likely that they have the 
capacity to degrade all the major components of the 
extracellular matrix (Jones and De Clerck. 1982). The way in 
which tumour cells might penetrate the basement membrane can 
be seen using re-constituted matrix gels of collagen, Lm and 
entactin. Initially, some of the tumour cells penetrate the
barrier leaving channels in the gel (Kramer e..t al, 1986) and
others follow through the channels. At the front of the 
invading cells, irregular pseudopodia are projected in the 
direction of migration which implies that focal hydrolysis of 
the matrix occurs at the adhesion contact between pseudopodia 
and matrix molecules. Presumably, at the site of invasion, 
proteolytic enzymes are released from the pseudopodia of 
tumour cells and once the matrix substance has been removed 
the tumour cells are able to migrate forward (Terranova,
1986). Proteinase activity released by the tumour cells 
therefore helps the cells to penetrate the barriers. Evidence 
supporting this is that a greater proteinase activity is 
released by malignant tissue compared with control tissues
(Liotta e.,t .a.I, 1980). Furthermore, using a metabol ical ly
labelled, basal lamin-like matrix to monitor the release of 
radio-label on exposure to tumour cells, it is possible to 
identify the components which are susceptible to enzymatic
degradation (Nakaj ima ,e„t , 1983). The evidence that
proteolytic degradation of BM plays a role in invasion
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includes the following: 1) that tumour cells can actively
degrade BM or BM-related products in zltro (Liotta e.t ,
1980); 2) that purified proteases have been derived from
tumour cells which degrade BM collagen (Weiss, 1985); and 3) 
that protease inhibitors block or partially inhibit invasion 
in some model systems (Jones and De Clerck, 1982).
The major proteinases released by tumour cells (and 
sometimes by host tissue as a result of the tumour cells) 
include plasminogen activators, collagenases, proteoglycanases 
and cathepsins. Minor proteases include elastase, gelatinase 
and stromolysin (Tryggvason e,.t al, 1987) .
Plasminogen activators are serine proteolytic enzymes and 
play a part in the migration of tumour cells as follows: 
Plasminogen activators (PA) convert plasminogen in the 
extracellular matrix to plasmin which can degrade Lm, Fn and
entactin (Liotta ,e..fc «1, 1981; Balian .ai, 1979), and can
activate collagenases to degrade collagen. B16F10 cells use
PA and collagenase IV to invade the BM (Reich e..t al, 1988).
Control of PA is achieved through the tumour-promoting phorbol 
ester (TPA) and by oncogenic transformation (Quigley, 1979). 
Proteoglycanases degrade BM and connective tissue components 
during invasion and may expose the ground substance so that 
collagen is exposed to further collagenase activity.
Cathepsins can degrade Lm and proteoglycans (Laug ,g.t. al,
1983).
One way in which it is thought that the tumour cells are 
activated to migrate through the BM is by following a chemical
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gradient either chemotactical ly or haptotactical ly (Varani .§..t. 
al, 1985).
Chemotaxis may be defined as the directed migration of 
cells in response to a soluble gradient of attractant (Lan,
1987). Haptotaxis, on the other hand, may be defined as the 
directed migration of cells in response to a substrate bound 
insoluble gradient of attractant (Lackie, 1986). Some of the 
factors known to promote chemotactic and/or haptotactic 
migration include the adhesion-promoting molecules discussed 
in Chapter III.
Perhaps the best characterised of the adhesion proteins 
which also promotes haptotaxis is Fn (Lacovara 1984) .
Lm and Vn also promote directional haptotactic migration over 
substratum bound gradients of the molecule (McCarthy 
1985; Basara and McCarthy, 1985; Iwamoto .at. .a.I, 1988).
The involvement of Fn, Lm and Vn in cell adhesion and 
spreading and in possible interactions with the cytoskeleton 
suggests a possible involvement in cell migration and, as has 
been reported, these molecules can promote cell migration in.
vJ..tr.Q. (McCarthy .at .a.1, 1986). This raises the possibility
that Fn-, Lm- and Vn-containing extracellular matrices might 
be involved in promoting and/or directing cell migration ,lo, 
O..K.Q. (Wewer .@.t._.aj.. 1987) . Since it was shown in the previous 
chapters that the endothelial cells synthesize Fn, Lm and Vn,
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the aim of this part of the study was to demonstrate the role
of the endothelial cells in tumour migration.
One way in which the tumour cells might migrate through 
the endothelial monolayer could be due to an increasing 
concentration (gradient) of molecules such as Fn, Lm and Vn 
from the apical surface of the endothelial cell to the
interstitium .in kIkq. (McCarthy et ai . 1985) . For example, it
is known that Lm and Fn are present at a high concentration in
the sub-endothelium compared with that on the apical surface 
of the endothelial cells (Kramer , 1980). It is possible
that the mechanism may be due either to adhesion to a natural 
gradient set up by proteins on the surface of the endothelial 
cells or in the extracellular matrix. On the other hand 
migration may be induced by some other mechanism which is not 
dependent on adhesion.
 )8jO!y..d e n .eli .. .as..s ay.
In 1962, Boyden introduced a technique for the 
measurement of chemotaxis of leucocytes. The chemotactic 
substance was separated from the cells by a micropore filter 
with pores of a size such that the cells were able to squeeze 
through the filter by actively migrating, but not to drop 
through it passively. The cells were allowed to settle on top 
of the filter and the chemotactic factor in solution was 
placed underneath. The chemotactic factor then diffused 
through to the top surface of the filter from below. Thus a 
concentration gradient was set up which was recognised by the 
cells on top of the filter. The gradient may either be
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soluble and non-established or insoluble and pre-established. 
Investigations using Boyden chambers included work on Fn 
(McCarthy and Furcht, 1984), Lm (McCarthy and Furcht. 1984) 
and Vn (Basara and McCarthy, 1985) on the assumption that 
tumour cells in blood-borne metastasis encounter gradients of 
these or other proteins in and around the endothelial lining.
This method, is a useful technique for measuring the 
migration of cells towards chemoattractants. The technique is 
versatile since the chemoattractants may or may not be 
substrate bound (haptotaxis and chemotaxis respectively) and 
may or may not be in the form of a gradient (taxis as opposed 
to kinesis). Furthermore, it is useful in that inhibitors to 
migration can also be used.
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5.,, 2 MATERIALS AND„.,.ffiTHODS
5.„^.2„,„1 M,ig,ration assay, in Boyd&n. G,hamber,s.
A 13mm diameter polycarbonate filter (Nucleopore - Bum 
pore size), was applied dull side up with UHU glue to a 2.5ml 
syringe which had been sawn off at the 0.2ml level. This 
formed the upper chamber, while the lower chamber consisted of 
a 5m1 Teklab tube (see Fig 22).
The B16F10 cells were harvested as usual and resuspended 
in serum free EC medium to 1x10* cells/ml. Cell suspension
(160ul) was placed in the upper chamber with 40ul serum free 
EC medium in the cases of chemotaxis^ and random^ locomotion 
or with 40ul presumptive attractant in PBS in the case of 
chemokinesis^. In the lower chamber. IDOul chemoattractant 
solution was added to 400ul serum free EC medium for 
chemotaxis or chemokinesis. For random testing only 500ul 
medium and no protein was added. In the case of haptotaxis» 
the lower chamber contained lOOul protein to 400ul medium and 
the upper chamber 200ul medium, This apparatus was left 
overnight at 37*C. The next day both chambers were washed 
twice with PBS and re-assembled. This time the lower chamber 
contained 500ul medium and the upper chamber contained 160ul 
cells and 40ul medium, TABLES 10 and 11 show a summary of the 
constituents in the upper and lower chambers.
1 Directional locomotion of cells to a concentration gradient o f a soluble attractant
2  Locomotion o f cells in the absence o f an attractant
3 Locomotion of cells in the presence o f a soluble chemical attractant, but not in the form of a gradient
4  Directional locomotion of cells to a concentration Radient of a substrate bound chemical attractant
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Fig 2 shows a schematic representation of a Boyden Chamber.
sgnnge
barrel
teklab
tu b e  *
upper
chamber
•nucleopore filter 
lower chamber
TABLE 10
Chemokinesis. chemotaxis and random locomotion:
Chemotaxis - soluble gradient of attractant in lower chamber 
Chemokinesis - soluble attractant in lower and upper chambers 
Random - no attractant
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LOWER CHAMBER
chemokinesis chemotaxis random
lOOul protein lOOul protein 500ul medium
400ul medium 400ul medium
UPPER CHAMBER
chemokinesis chemotaxis random
160ul cells 160ul cells 160ul cells
40ul protein 40ul medium 40ul medium
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For all types of migration the chambers were covered over 
with cling film and left at 37'=’C for 4h in an incubator. At 
the end of the incubation period the syringe barrels were 
placed into a holder and immersed in 96% alcohol for 2.5min to 
enable the filters to be peeled off. The filters were then 
re-placed into the holder dull side up and stained as 
described in Appendix 1.
TABLE 11 
Haptotaxis:
Haptotaxis - insoluble gradient of attractant within the filter
LOWER CHAMBER
overnight incubation experimental conditions
lOOul protein SOOul medium
400ul medium
UPPER CHAMBER
overnight incubation experimental conditions
200ul medium 160ul ceUs
40ul medium
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The top of the filters (dull side) were then wiped with 
cotton wool soaked in 100% ethanol before being left in xylene 
for 2min. After this time the filters were mounted onto glass 
slides (dull side up) using styrene. Spread cells which had 
migrated through each filter were scored in 18 fields of view 
at x20 objective lens magnification. The mean number of 
cells/cm^ was calculated.
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5...,...3 RESULTS
In this part of the study, proteins extracted from the 
endothelium were studied in a Boyden chamber assy to see if 
they would promote migration. A comparison was made of the 
chemotactic, chemokinetic, haptotactic and random movements of 
B16F10 cells to the endothelial derived extracts (CE and CEM). 
Fn and Lm were used as positive controls and FCS and CFE were 
used as further controls.
Chemotaxis, haptotaxis and chemokinesis dose-response 
curves were set up using CE (0.07-700ug/ml), CEM (4ug/ml- 
4mg/ml) , Fn (5-40ug/ml) , Lm (10-50ug/ml) and FCS (4ug/ml~ 
4mg/ml) . The mean number of migrated cells at x20 objective 
lens magnification was calculated from 18 readings per filter.
There was no migration response to CE.
There was no migration response to CEM.
c.)....._F.CB a.D.d ce.l„l f.re„e co,ntro.l.s
There was no migration response to these proteins.
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.d). En
The peak responses for chemotaxis, chemokinesis and 
haptotaxis caused by Fn were at 20ug/ml, 20ug/ml and 30ug/ml 
respectively as shown in TABLE 12. The peak responses for 
chemotaxis and haptotaxis were similar (although haptotaxis 
was higher) , but for chemokinesis the peak response was about 
12x lower than that for chemotaxis or haptotaxis. Using 
analysis of variance (ANOVA) the results indicated that 
chemotaxis and chemokinesis were significantly different 
(F-2775.7, (df;l,20)) ; values obtained for chemotaxis and
haptotaxis were significantly different (F-3791.4, (df:l,20))
as were values obtained for chemokinesis and haptotaxis 
(F-10908.7, (df:1,20)).
.Q.) Lm
The peak responses for chemotaxis, chemokinesis and 
haptotaxis for Lm were at or above 50ug/ml, 50ug/ml and at 
40ug/ml respectively as shown in Fig 23 and TABLE 13. It may 
be that the peak responses for chemotaxis and chemokinesis are 
above 50ug/ml, but without using more concentrated solutions 
(due to the high cost of Lm) this could not be determined. 
However it could be seen that the peak response for chemotaxis 
would be higher than that for haptotaxis which is in contrast 
to what occurs for Fn.
It was observed that prior to wiping the surface of the 
filters, the way in which the cells settle on the filter 
differs for the various proteins. For Fn and Lm, the cells
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settled thickly on the top surface. However, for FCS, CE and 
CEM, very few cells appeared to cover the surface of the 
filter. When the filters were examined using an inverted 
microscope, before wiping, it was observed that for FCS, CEM 
and CE that the cells were aggregated. One possibility worth 
considering is that the aggregated cells were unable to 
migrate through the pores. This aggregation phenomenon was 
observed when cells were suspended in a solution of these 
proteins but to a much lesser extent in Fn and Lm. (See 
Appendix 8).
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TABLE 12 shows chemotaxis. chemokinesis and haptotaxis locomotion of B16F10 
cells to Fn. n=3
Fn conc Chemotaxis cells,nioved / e n /  i  S.D.
Chemokinesis 
cell&nmved /cm^ ± S.D.
Haptotaxis 
cell&moved /en ?  ±  S.D.
5ug/ml 340.9 ±  13.0 13.6 ±  2.1 25.0 ± 1.0
lOug/ml 363.6 ±  13.0 13.6 ±  1.2 288.6 ± 4.2
20ug/ml 397.7 ± 29.5 47.7 ± 3.2 350.0 ± 13.6
30ug/ml 211.4 ± 13.5 20.5 ± 2.2 431.8 ± 12.1
40ug/ml 179.5 ± 9.5 11.7 ± 4.4 284.1 ± 7.2
TABLE 15 shows chemotaxis. chemokinesis and haptotaxis locomotion of B16F10 
cells to Lm. n=3
Lm conc Chemotaxis cell^^nioved /e n ?  S.D.
Chemokinesis cell&nmved /cm^ ± S.D.
Haptotaxis 
celknmved /cm^ ± S.D.
lOug/ml 0.0 ± 0.0 13.6 ± 3.0 211.4 ±  9.5
20ug/ml 22.7 ± 3.5 47.7 ±  3.2 468.2 ± 13.0
30ug/ml 145.5 ±  8.2 50.0 ±  2.9 518.2 ±  20.3
40ug/ml 195.5 ±  10.2 113.6 ±  8.1 540.9 ±  21.2
. 50ug/ml 570.5 ± 29.0 293.2 ± 12.0 475.0 ± 19.6
22 shows the migration response of B15F10 cells to Fn.
SB is shown in Ti^ BLE 12. 176
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B16F10 cells to Lm.
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The B16 cells showed a greater response to Lm than to Fn 
for chemotaxis (nearly 1.5x) and chemokinesis (nearly 6x) but 
for haptotaxis migration was about the same, at their peak 
responses. For each protein, the response was also different 
in that for Fn the cell migrated in greater numbers to an 
insoluble gradient (haptotaxis), whereas for Lm they migrated 
in greater numbers to a soluble gradient (chemotaxis) and with 
an increase in random movement in the presence of Lm 
(chemkinesis).
All control values obtained in the absence of attractant 
were zero and tests of significance performed between controls 
and data for chemotaxis, chemokinesis and haptotaxis gave 
highly significant p-values except where the cells failed to 
migrate.
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 m . ü Q m m . m
The Boyden chamber assay used in this study has enabled 
an investigation of the molecules which may be involved in 
promoting migration.
.
Although the endothelial derived proteins have been shown 
to contain Lm (in the case of CE) and Fn and Vn (in the case
of CEM), in the Boyden chamber assay these proteins did not
promote migration. One possibility is that the aggregation 
promoting properties which these extracts also exhibit (see 
Appendix 8) , result in the B16F10 cells becoming aggregated. 
In the Boyden chamber assay, this would mean that the tumour 
cells would be unable to migrate through the 8um pores of the 
nucleopore filter. Alternatively, there may be an inhibitory 
molecule present in the extracts, which while allowing
spreading and adhesion to take place, inhibits migration. One 
way to investigate either of these suggestions would be to 
purify the endothelial extracts by iramunoaffinity 
chromatography and gel filtration as has been outlined before 
and then to test the purified molecules in the Boyden chamber 
for inhibition and promotion of migration of B16F10 cells.
The results for migration to Fn indicated that it
occurred mainly by chemotaxis and haptotaxis. It would appear 
that the peak response for chemotaxis occurred at a lower 
concentration (30ug/ml) than it did for haptotaxis (40ug/ml) .
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This suggests that functionally one of two mechanisms might be 
employed during migration depending on the concentration of Fn 
present. It would appear that the concentration gradient is 
important whether soluble or insoluble.
The results for Lm indicated that migration occurred 
through chemotaxis, haptotaxis and possible to lesser extent 
chemokinesis. It would appear though, in contrast to Fn, that 
chemotaxis occurred at a higher concentration (not 
determinable but at or higher than 50ug/ml). Although 
chemotaxis is higher than haptotaxis, haptotaxis is probably 
physiologically more relevant. It should also be noted that 
random movement in the presence of Lm was significantly 
increased. This was in agreement with the results obtained by
Situ .e..t al (1984) who used highly malignant murine
fibrosarcoma cells. The potential sigfnificance of haptotaxis 
to Lm and Fn in the metastatic process is suggested by the 
studies of Varani (1982) which show a correlation between 
tumour cell metastatic potential and cell attachment rates to 
insolubilised endothelial and subendotheliai components.
Although Lm and Fn have been shown to promote the 
migration of a number of tumour cell types in the Boyden 
chamber assay system, there seems to be little agreement 
amongst investigators as to the dose-response range and peak
response values for B16 cells. Lacovara fit A.l (1984) have
reported that concentrations of Fn below 50ug/ml do not elicit
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an increase in migration over 300ug/ml. McCarthy (1984), on 
the other hand, has reported that the stimulation of migration 
occurred over a concentration range of 1-lOOug/ml for Lm and 
Fn, with a peak value occurring between 12 and 25ug/ml for 
haptotaxis. These results compare better with the results of 
this study where a peak response for Fn was 30ug/ml and Lm was 
40ug/ml. High concentrations of the Lm and Fn used in
McCarthy's experiments and in the experiments of this thesis 
indicate that there is a fall-off from the peak values. This 
suggests that at high concentrations of Fn and Lm that the
cells may become desensitised and no longer react to the 
molecules. The difference in results suggests that the Fn
used by Lacovara was either impure or inactive through bad 
handling during its preparation.
 „.,M..i)i..9!.r.a.t.,3i..Q..o in  m.^ i..J...i..sm.an.c.y.
Although the finding that tumour cells migrate along 
insoluble, positive gradients of Lm and Fn is relevant to
metastasis, it is not necessarily the case that gradients of
adhesive proteins exist m„„ i.e. proteins could be
distributed randomly throughout the extracellular matrix. If 
this is the case, then it is still possible that active 
metastasis could occur as both Fn and Lm have been shown to
accelerate the random movement of cells in the Boyden chamber
assay system in this investigation and also by other workers
(McCarthy 1984; Lacovara  ,a,l, 1984). There is also
the fact that cells use specific enzymes to degrade matrix
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proteins, thereby creating gradients in their paths by loss of 
Lm and collagen (Barsky .et , 1983) .
It is also plausible to propose that a natural gradient 
of protein(s) exists across the endothelial monolayer. Lm and 
Fn are present, at relatively high concentrations in the 
subendotheliai basal lamina in contrast to the low levels 
found on the endothelial cell apical surface (Birdwell ,a.I,
1978; Kramer  «1, 1980) and this might represent a natural
gradient. This might also explain why CE does not promote 
migration. Similarly, Lm, which is localised in the BM has 
been shown in this study to be much more potent at attracting 
B16 cells than Fn, and therefore it is possible that the
relative localisation of these proteins in ¥.i.v.Q may serve to
provide a natural gradient which stimulates tumour cells to 
extravasate.
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.6,1 CONCLUDING RENAEKS,
The successful colonization of distant host sites by 
metastatic tumour cells proceeds by a series of complex 
sequential steps (Nicolson and Winklehake, 1975), that depend 
upon the abilities of the tumour cells to invade surrounding 
tissues (Weiss, 1976), enter and circulate in the blood stream
(Kramer .et. .ai, 1982) , implant in the circulatory system
(Fidler .e..t. al, 1975), extravasate or invade the capillary
endothelium (Poste and Fidler, 1980), migrate to extravascular
sites (Terranova .e,.t. al., 1986) and establish a microenvironment
for subsequent vascularization and growth (Folkman and 
HaudenschiId, 1980).
Blood-borne metastatic tumour cells adherent to the 
capillaries must invade both the endothelial cell layer and 
the sub-endothelial BM (Jones and De Clerck, 1982) . This is 
thought to occur by a combination of enzymatic and mechanical
destruction (Liotta ..e..t al, 1980; Chew , 1976) . Since the
basement membrane consists of collagen, fibronectin, laminin 
and a variety of other proteoglycans and glycoproteins, 
destruction of the matrix by invading cells may require a 
variety of hydrolases which act sequentially to solubilize the 
matrix and permit its penetration by metastatic cells (Liotta, 
1986).
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.6.../...2.......XUHQUHz:END.D.THELIAL......,C.ELL.„...I.HXE.RA.C,X.I.0N.S,
Using an ,lo Kltr.0 model, certain morphological and
biochemical aspects of tumour cell (B16F10) interactions with 
endothelial cells (BAE) can be studied. The results show that 
B16F10 cells (either as single cells or as aggregates) are 
capable of adhering to the apical surfaces of endothelial 
cells, induce rupture of endothelial cell junctions, followed 
by peeling back of the endothelial cells from their underlying 
matrix and migration to the exposed subendothe1ial matrix. 
The exact mechanisms employed by the tumour cells could not be 
identified. However, it is likely that adhesion was caused by 
macromolecules on the surface of the endothelial cells, that 
rupture of the intercellular junctions occurred through 
enzymic degradation and the underlying matrix was important in 
the processes of spreading and migration.
 ,QE lAE...,..C,ELL.g!. m.„._IUMQUE .CELL ADHEEIM
Since it seemed likely that the endothelium might prove 
to be a source of adhesion promoting molecules, proteins were 
extracted from the surface of the BAE cells using 2mM EDTA 
(CE) and from the conditioned medium (CEM) . These molecules
were shown to promote adhesion in a dot blot assay and partial
characterisation of them was achieved using SDS-PAGE and 
antibody immunoprobing. From these analyses it was concluded
that the active components in CE were Lm and possible a 37kD
protein which was not identified, but which might be similar
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to a molecule reportedly involved in metastasis (Steinman .e.t 
al, 1984). The active molecules in CEM were an 187kD fragment 
of Fn and Vn complexed with ATI II . These results are in
agreement with reports by Hatcher e..t. ,«i. (1986) and Preissner
(1988) . However, Preissner e U I  (1988) put forward the 
suggestion that these molecules are involved in inflammation 
and repair mechanisms. It may be that the processes of 
inflammation, tissue repair and tumour cell extravasation are 
closely inter-related, as reviewed by Sporn and Roberts 
(1986). In brief, Sporn and Roberts state that biochemical 
mechanisms by which cells and tissues respond to injury and 
initiate the repair process are now known to be highly 
relevant to the study of carcinogenesis. More recent evidence 
comes from studies which have shown the role of growth factors 
in the malignant process which are also expressed 
physiologically by cells that mediate inflammation and repair 
- namely platelets, macrophages and lymphocytes.
Use of antibodies in the inhibition of adhesion indicated 
that total inhibition by any single antibody could not be 
achieved. Therefore it remains to be seen whether a 
combination of antibodies could achieve this end. This was 
not possible through lack of time.
6,...4,...THE ROLE OF ENDOTHELIAL CELLS IN TUMOUR CELL SP.RE.AD
In order to strengthen the interaction of the tumour 
cells with the endothelium, it was necessary for the tumour 
cells to spread. It seemed possible that the molecules
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involved in the adhesion process might also be involved in 
promoting spreading. Hence, the molecules which had been 
extracted from the endothelial cell surface and the 
conditioned medium were tested for their spreading-promoting 
properties. The antibodies raised for testing in the cell 
attachment assay were also used to try and inhibit spreading. 
As for adhesion, CE and CEM promoted spreading of B16F10 
cells. The antibodies which inhibited adhesion to CEM also 
inhibited spreading, but none of the antibodies tested 
inhibited spreading to CE.
From these results, it was concluded that the 187kD 
component from CEM, thought to be a fragment of Fn and the 
Vn/ATIII complex, promoted spreading as well as adhesion. On 
the other hand, spreading to CE could not be attributed to 
either Lm or the 37kD component, both of which had been shown 
to promote adhesion. It may be that molecules other than 
these proteins are involved in promoting spreading, or 
alternatively that Lm and the 37kD do promote spreading 
together with each other and/or with other components. One 
way of eliminating these possibilities would be to raise 
antibodies to the purified 37kD component and to use this in 
combination with anti-Lm to try and inhibit spreading.
Interest in the migration of tumour cells has been 
fuelled by its relevance to the process of metastasis, and
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much research has been done in this area to reveal the 
molecules that tumour cells utilise in adherence and movement 
through tissues during invasion.
Migration follows spreading and so the molecules which 
had been shown to be adhesive and to promote spreading were 
tested in Boyden chambers for their migration-promoting 
properties. Neither of the cell derived extracts promoted 
migration, but Fn and Lm which had been used as positive 
controls did. One reason suggested was that the endothelial 
extracts caused the tumour cells to aggregate which would not 
allow them to migrate through the pores of the filter used in 
the Boyden chamber assay. In order to demonstrate the role of 
endothelial cells in promoting tumour cell migration it would 
be necessary either to purify the extracts or to use a 
different system for measuring migration. From the results 
presented in this thesis, the role of endothelial cells is to 
provide a barrier against the tumour cells. The role of these 
cells in promoting migration has not been shown. However, the 
molecules which are known to promote migration are found on 
the endothelial cells. It is therefore likely that the 
endothelium-plays a role in promoting tumour migration.
6...,..6. CONCLUSION
In conclusion, it can be seen that the endothelial cells 
play a vital role in spreading and adhesion; their role in 
migration has not been proven in this study, but is likely. 
These preliminary results have therefore shown potential for
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further studies in this area of investigation.
This study has indicated possible molecules which are 
involved in adhesion, spreading and possibly migration. The 
results suggest possible directions for in vivo studies and 
has contributed to knowledge in that it has narrowed the field 
so that future investigations may be confined to a small 
number of types of molecule. For future work on these 
molecules, it would be necessary to purify them using methods 
already outlined. The ultimate aim of further work would be 
in the testing of the purified molecules and monoclonal
antibodies raised against them in la „...v.i.KQ. studies. The
antibodies could be used at different stages in extravasation 
- cell adhesion, spreading or migration - to see which step 
can be blocked in order to successfully prevent the tumour 
cells from forming métastasés. It may be that the 
situation. However, the possible beneficial effects in the 
clinical situation which could ensue means that these results 
cannot be disregarded as they may be of help in evaluating 
future ln..^.vlv..Q. studies.

1. Dulbecco^s phosphate buffered saline (PBS) pH7.2
component concentration g/1
N aO 8.0
KCl 0.2
Na2 HP0 4 .2 H 2 0 1.15
KH2 PO4 0.2
CaCl2 0.1
MgCl2 .6 H 2 0 0.1
Made up in distilled water and adjusted to pH7.2 with HCl.
2 . Dulbecco's calcium magnesium free phosphate buffered saline (CMF-PBSl pH7.2
Same as above, but without the last two ingredients. Adjusted to pH7.2 with
HQ.
3. Borate buffer IQx pH8.7
Component Concentration g/1
H 3 BO3 6.2
MgCl2 .6 H 2 0 2.0
NaCl 58.4
Made up in distilled water and adjusted to pH8.7 with IM NaOH.
4. Phosphate buffer x5 pH8.0
Solution Component Cone, g/1
A Na2 HPO4 .1 0H 2 O 179.0
B NaH2 P0 4 .2 H2 0 78.0
Solutions A and B were made up in distilled water. Solution B was added to 
solution A to bring the pH to 8.0.
5. Citrate buffer x5 üH6.5. 4.5 or 3.5
Solution Component 
A NagCgHgO'y.ZHgO 
B C^HgO?
Cone, g/1
147.0
105.0
Solutions A and B were made up in distilled water. Solution A was added to B
or B to A as appropriate to bring the pH to 6.0, 4.5 or 3.5.
6 . Carbonate buffer pHll.O
component Concentration g/1
Na2 COg 1.59
NaHCOg 2.93
Made up in distilled water and the pH adjusted to 11.0.
7. Ortho-phenvlenediamine
0.04% ortho-phenylenediamine and 0.012% hydrogen peroxide were dissolved 
in phosphate-citrate buffer, pH5.0.
8 .Phosphate-citrate buffer, pH5.0
Solution Component Cone, g/1
A Na2 HPO4 .1 0H 2 O 21.0
B CgHgO, 28.3
9. Protocol for making up different percentage SDS containing polvacrvlamidc gel 
solutions
SOLUTION POLYACRYLAMIDE CONC. 
5% 10% 15%
30% acrylamide 5.0 10.0 15.0
1 % bisacrylamide 7.8 3.9 2.6
1.5M tris-Pia pH8.7 7.5 7.5 7.5
distilled water 9.3 8.2 4.5
1 0 % ammonium persulphate 0.2 0 .2 0 . 2
10% SDS 0.3 0.3 0.3
TEMED 0 . 0 2 0 . 0 2 0 . 0 2
Volumes are given in ml/gel.
JQ. Protocol for staining the filters
SOLUTION time (mins)
96% ethanol 2
70% ethanol 2
distilled water 2
Mayer’s Haematoxylin 5
tap water 2
70% ethanol 2
1 0 0 % ethanol 4
2 -
The following diagram shows the metabolic pathways relevant to hybrid 
selection in HAT medium. When the main systhetic pathway for guanosine is blocked 
by the folic acid antagonist aminopterin, the cell must use the salvage enzymes HGPRT 
(hypoxanthine guanine phosphoribosyl transferase) and TK (thymidine kinase). Cells 
lacking HGPRT (such as the .TKAgS cells) die in medium containing hypoxanthine, 
aminopterin and tymidine (HAT) since they are unable to use the salvage pathways. 
However, if these cells are fused with cells that contain HGPRT (such as spleen cells) 
they will survive in HAT medium.
5-amino imidazole-
4-carboxy ribonucleotide
AMINOPTERINi
HYPOXANTHINE
(HGPRT)
5-formido-imidazole- 
4-carboxamide ribonucleotide
tIMP
p- (inosine monophosphate)
*GMPGuanine (guanosine monophosphate)
THYMIDINE
(TK)
dTMP(deoxythymidylate) p^DNAt (deoxy ribonucleic acid)AMINOPTERIN
UDP
(uridine 5' diphophate)
APPENDIX 3 - WESTERN BLOTTING ADHESION MOLECULES
Blotting analysts of adhesive proteins: an evaluation of the technique using B16F10 malignant
melanoma cells
VALERIE FERRO. CORRADO D’ARRIGO,DAVID OGDEN and CUVE W. EVANS 
Department o f Biology and Preclinical Medicine, University o f  
St. Andrews, Bute Medical Buildings, St. Andrews, FHe KYI6 9TS, U.K.
The identificatioR of adhesive molecules can proceed in 
several different ways, but ooe of the most convenient 
involves the adsorption of a putative adhesive molecule on to 
an artificial substrate (such as tissue culture plastic) followed 
by probing the adsorbed material with a suspension of cells. 
In the absence of protein in the suspending medium, most 
cells adsorb non-speciffcally to tissue culture plastic and thus 
any sites not occupied by the adsorbed adhesive molecules 
under test must be blocked with a non-adhesive agent such as albumin. The major problem of identifying an adhesive 
protein, however, is not so much in showing that cells adhere 
to it, but more in how to identify it from a complex mixture 
of molecules which may have been extracted from whole 
cells or multicomponent substrates. Within a mixture of
Abbreviations used: PAGE, polyacrylamide-gel electrophoresis; 
Fh, fibronectin; PBS, phosphate-buffered saline; CE, cell extract; 
BAE, bovine aortic endothelial; Lm. laminin; ELISA enzyme- 
linked immunosorbent assay; 2 Me. 2-mercaptoethanol; TGS, 25 
nxM-Tris/192 mu-glycine/1 % (w/vi SDS electrophoresis buffer, 
TCM, 25 nui-Tris/192 mM-glydne/20% (v/v) methanol blotting buf­
fer.
molecules, some may block adhesion by competing for sub­
strate adsorption with the adhesive molecule, whüe others 
may interact with the molecule in question to effectively 
neutralize its adhesive properties. Some of these {vobiertts 
may be overcome if the mixture can be fractionated and the 
fractions tested in an adhesion assay. In the original report on 
cell blotting Cbioautograpfay') by Klebe et al, (1978), 
50-100% (v/v) serum was eiectrophoresed on cellular acetate and a d ^ sio n  replica was made by overlaying on to 
a gel of 0.25% iw/v) type I collagen. Material which did not 
bind to the collagen was eluted by washing, and any adhesive 
molecules were then identified by probing with 4x10^ CHO cells followW by fixing, and then staining with 0.1% (w/v) 
Toluidine Blue. Using this tech^ue, two adhesive barids were identified in serum: one by its isoelectric point (approx. pi 4.8) and the other by its extremely large size (failing to run 
into the gel). The main limitatioa of this study was associated 
with restriction of the analysis to those molecules which 
bound to collagen under the conditions of the experiment. 
Hayman et al. (1982) improved upon this technique by first 
depleting plasma of albumin and immunoglobulin G, and then by separating the remaining proteins using SDS/pc^y- acrylarnide-gel electrophoresis (PAGE) undw reducing 
conditions. A  replica of the electrophoretic pattern was then 
made by diffusion blotting of the separated molecule on to a 
nitrocellulose filter according to the method of Bowen et al. 
( 1980). After blotting, the filter was blocked with 5 mg of 
bovine scrum albumin/ml, probed with NRK cells (10’ cells
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in 50 ml), fixed and visualized by staining with 0.1% {w/v) 
Amido Black. Using this approach. Hayman «  al. (1982) 
were able to identify two adhesive molecules in plasma, one 
of Af, 220000 and the other of M, 70 000 (corresponding to 
fibronectin (Fn) and vitronectin, respectively]. Since these 
reports, numerous laboratories have attempted to use the 
blotting technique to identify adhesive proteins, but with 
mixed success. In order to further the use of this technique 
we have carried out a systematic study of the method and 
examined its shortcomings as a technical procedure.
Preparation o f adhesive proteins
Fibronectin {Fn« was either prepared from bovine blood by affinity chromatography on gelatin or it was purchased 
from Sigma. For affinity chromatography, plasma prepared 
from 50 ml of fresh blood (treated with 15 ml of standard 
acid/citrate/dextrose anticoagulant) was diluted 1:1 with phosphate-buffered saline (PBS), pH 12, and applied to a gelatin column (Biorad) equilibrated with PBS. Bound 
material was eluted with SO mw-sodium acetate buffer, pH 
5.0, containing 1 M-sodium bromide and dialysed against 
PBS before being sterile filtered and stored at 4*C.
Cell extract (CE > was prepared from cloned bovine aortic 
endothelial (BAE) cells (the gift of Dr. Jean R. Starkey, 
Montana State University, MT, U.S_A.). BrieSy, six roller 
bottles (growth area 750 cm^ ) were seeded with 6.5 x 10* BAE cells in 117 ml of Eagle's complete minimal essential 
medium as described by Elvin & Evans ( 1984), but further 
supplemented with endothelial cell growth factor (5 ng/tnl) 
and insulin (0.013 i.u./ml). On reachmg confluence (3 days), 
each bottle culture was washed three times with 100 ml of 
150 niM-NaCl in 20 mm-Tris (pH 7.5), and extracted by rolling for 30 min at 37*C with 10 ml of washing medium 
containing 2 mw-EDTA. The extracts were then pooled, 
centrifuged (30 min, 1500 g), concentrated against flake polyethylene glycol, and stored at 4*C. Some experiments 
used this etude extract, but for others the crude material was 
adjusted to 75 mw-NaCI and pH 8_3 immediately after 
extraction, and then applied to a column of Q Sepharose 
(Pharmacia). Bound material was eluted with 500 mw-NaCI 
in 20 mw-Tris (pH 8.3) and then applied to a column of Sepharose G200 (Pharmacia). A high M, ( > 600000) eluting 
in the void volume was found to have adhesive-promoting activity.
Laminin (Lm) was purchased direct from Sign^ Protein 
coiKentrations were determined by a modification of the Lowry method (Larson «a/., 1986).
Cell probing o f dot-hlots
Briefly, protein samples (about 1 /d) were dotted directly 
on to a nitrocellulose filter (BA85; Schleicher and Schuell, 
Inc.), blocked with 10% (w/v) bovine serum albumin, and then incubated with B16F10 cells (minimum 5 x lO^percm^ 
of filter) suspended in serum-free complete minimal essential 
medium. After 2 h the filter was washed with 10 ml of P K  
per cm  ^ of filter) dispensed from a syringe through a 19- 
gauge needle, and the remaining cells were then fixed with 70% (v/v) ethanol and stained with Mayer's haemahim. The 
sensitivity of the ceil probing assay was tested on 10-fold 
serial dilutions of Lm, fh  and CE, and the results were com­
pared with detcctkm by enzyme-linked immunosorbent 
assay (ELISA) using a phosphatase-labelled second antibody 
detection system. Using this ELiSArbased approach, the 
adhesive molecules were detectable down to 50 ng, 5 ng and 
150 ng, respectively. Using the cell probing method, recogni­tion of Lm (as judged by adhesive cells) seemed to be as 
sensitive as u s i^  ELISA (50 ng), whereas the detection of Fn 
was more sensitive since as little 0.5 ng applied to the fiber
promoted adhesion. Like the results with Lm, cell probing of 
CE was as sensitive as ELISA 1 150 ng). Although these 
results are dependent on the nature of the antibodies 
employed, they nevertheless provide an indication of the 
relative sensitivity of the cell probing method for identifying 
adhesive molecules. Interestingly, in the original study of 
Klebe et al. {1978), the serum molecule of pi 4.8 with 
adhesive activity was not readily detectable on Coomassie- 
Blue-stained gels, and thus cell probing may have consider­
able sensitivity over this general staining method for the 
recognition of adhesive molecules.The effects of various electrophoresis and electrobiotting 
reagents on cell probing were also tested using the dot-blot­
ting procedure. As summarized in Table 1, 0.625% (w/v) SDS in PBS with or without 10% (v/v) 2-mercaploethanol (2- 
Me inhibited the adhesion of B16F10 cells to doi-blots of 
Lm 250 ng), Fn (275 ng) or CE ( 75 ng). The inhibitory effect 
of SDS on adhesion was also seen when the dot-blots were treated with 25 mw-Tris/192 mw-glycine/1% iw.'v) SDS 
electrophoresis buffer (TGS). The irthibitory effects of SDS 
and/or 2-Me were not overcome by additional washing with 
25 mw-Tris/192 mw-glycine/20^t (w/v) methanol blotting 
buffer (TGM) before cell probing, and it would thus seem 
likely that they result from the denaturing effects of SDS 
and/or 2-Me on the proteins tested. Regardless of the 
mechanism involved, these preliminary studies suggest that 
fewer problems might be expected with cell probing if the electrophoretic separation of putative adhesion molecules is 
performed in the absence of SDS and 2-Me.
Electrophoresis and electroblotting
SDS/PAGE was performed on 7.5% (w/v) slab gels under 
both non-reducing (0.625%, w/v, SDS in the sample) and reducing conditions (0,625%, w/v, SDS plus 10%, v/v, 
2-Me). Flat bed agarose electrophoresis of non-denatured material was carriW out over 2 h at 200 V using 1% (w/v) 
gels prepared in Tris/acetate buffer, pH 7.8. Electroblotting 
(Western blotting) was performed from both types of gels in a 
Transblot system (Biorad), using TGM at pH 8.3 as the 
running buffer for SDS/PAGE (Towbin et al., 1979) and methanol-free TGM for agarose gels. Electroblots were 
blocked with 10% (w/v) BSA in PBS for 30-60 min at 37*C 
and then probed with B16F10 melanoma cells as described 
above. Protein bands in gels and blots were identified by 
staining with 0.02% (w/v) Coomasste Blue and 0.1% (w/v) 
Amido Black, respectively.
When Lm (20 ^g), FN (22 ^g) and CE (6 pg) were subjected to SDS/PAGE under reducing and non-reducing
Table 1. Effects o f electrophoresis and bhtting agents on 
adhesion
Proteins were pretreaied with the various reagents under condi­
tions similar to those in which they would be used for electro­
phoresis or electroblotting The resuhs are expressed on a semi-quantitative scale in which the reaction with each protein 
under control conditions (PBS) was taken as 5 +.
Reagent R i(275ng) Lm{250ng) C E(75ng)
PBS
SDS
SDS+TGM  wash 
SDS + 2-Me
SDS + 2-Me + TOM wash
1,5M-Tris
TGS
TGM
5 + 1 +
5 + 
1 + 
5 +
5 +
5 + 1 + 
5 +
5 +
3 +
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(Cl in electrophoresis as shown by standard doi-bkx assays. 
Nevertheless, these resuhs were essentially as expected from 
our preliminary studies based on dot-blots. which identified 
initiatory effects of SOS and/or 2-Me on adheskm. Con­
sequently, we next used noo-denatuhng conditions to test for 
adhesive activity after eiectrobkttting of electrophoreticaily 
separated proteins. Fig. 1 shows an electroblot of Lm, Fh and 
crude CE eiectrophoresed in agarose under non-denaturing conditions and probed whh B16F10 cells. The adherence 
activity of Lm is seen to reside in a sharp band, whereas that 
for Fn is more diffuse. .Adherence of B16F10 cells to CE was 
seen to be localized over the origin, suggesting that this 
extract contained matenal which behaved differently to both 
Lm and Fn under these experimental conditions.
In our hands, the use of non-denaturing electrophoresis provides more consistent results on subsequent cell probing 
than does denaturing electrophoresis. Although it is difficult 
to resolve mixtures of proteins by M, using agarose electro­
phoresis, this limitation should be overcome through the use 
of non-denaturing PAGE (Bryan, 1977) and considerable 
benefits may also accrue from the use of isoelectrofocusing. 
In generaL electroblotting seemed to be without significant effect on subsequent cell adhesion. There thus appears to be 
little advantage in the use of diffusion blotting for the transfer 
of adhesive molecules, although this method was employed 
originally by both Klebe er al. (1978) and Hayman er al. 
(1982). We conclude that cell probing of electroblotted molecules after séparation by electrophoresis can be a sensi­
tive method for detecting adhesive substarKes. particularly if 
non-denaturing conditions are employed. Clarification of the 
role of CE in the adhesion of malignant melanoma cells to 
the endothelium during the process of blood-bome meta­
stasis is currently under sttxly.
Fig 1. Adhesion o f B16FWcells to electroblots
Samples of Lm (a), Fh (h) and CE (c) were eiectrophoresed 
in agarose, electroblotted on to nitrocellulose and probed 
with B16F10 melanoma cells as described in the text. Note 
that the adhesive activity of Fn did not resolve into a sharp 
band like Lm, and that the adhesive activity of CE (known to 
be of high .M,) remained at the origin.
conditions, dectrobkxted and then probed with B16F10 
cells, the results did not always indicate adhesive activity. 
Electroblots of Lm and purified CE, for example, faded to 
show any adhesive activity, while electroblots of Fn were 
adhesive only under non-reducing conditions. A3 three of 
these molecules are adhesive at the concentratioru employed
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Test panel of the effect of electrophoresis and electroblotting reagents on adhesion
TEST MOLECULE (amount blotted)
Reagent Fn Lm CE CEM
1. PBS 5+ 5+ 5H- 54-
2. SDS
3. SDS + 2-Me/ 
SDS + 2-Me
1 + 1+
+ WBB wash - - - -
4. 1.5M tris-HCl 5+ 5+ 44- 44-
5. EBB 1 + 1 + - 24-
6 . WBB 5+ 5+ 34- 34-
See paper for details on concentrations and abbreviations. The photograph 
shows the effects of electrophoresis and Western blotting reagents on B16F10 cell 
adhesion to Fn, Lm and CEI. CEI is the same as CE.
E F F E C T  O F  A G E N T S  O N  A D H E S I O N
A G E N T F n L m C E I
T.
APPENDIX 4 - GEL DRYING PAPER
Use of a rapid method for dehydrating polyacrylamide gels after electrophoresis of cell adhesion
molecules
VALERIE A. FERRO. JAMES F AITON and 
GORDON CRAMB
Department o f  Biology- a nd  Preclinical Medicine. University o f  
5t Andrews. Bute .Medical Buildings. St Andrews. Fife K Y I6
9T5. U.K.
SDS polyacrylamkk-fel electrophoresis (PAGE) is fre­
quently used for separation and molecular mass estunation 
of protein components in various biolopcal extracts. One of 
the major problems encountered with this technique is 
assoaated with identification and quantification of minor 
protein components in the extract, in addition, long-term 
storage of wet gels for future reference often causes prob­
lems dtie to storage space and the bleaching of dye from 
stained proteins. At present gels are stored ehher wet m de- 
staining solution or are more commonly dehydrated on to 
fiher paper using a commercial drying apparatus. Although 
the latter method is conveniem for storage of large numbers 
of samples, dehydration is time consuming and gels are often 
susceptible to cracking a t  distortkm during the drying 
process, especially if they are thicker than 1J  mm (Hames, 
1987VIn this report, a simple and inexpensive procedure is 
described for rapidly extracting up to 90% of the water from 
gels before final dehydration 1^ vacuum aspiration. Advan­
tages of this method are that thick y is  do not crack, are less 
susceptible to distonion and in addition a greater number of 
geb can be processed much quicker than has been possible 
in the past.
We have been using this tecluique for the identificatk» of 
endothelial cell proteins which promote adhesion and 
spreadmg of 816 melaooma cefls (Ferro er a/., 1988). Cefls 
grow  in roller bottles for 3 days were washed with 
caknim-magnesium-frec phosphate-buffered saline (CMF- 
PBS) and thra the surface proteins were extracted by roOuig 
for 10 min at 37*C with 25 ml of 2 him-EOTA in CMF-PBS 
to give cefl extract (CEL Control bottles containing medium 
without cefls were sundarty treated to give ceO-free extract 
(CFEL The extracts were dialysed against distilled water, 
concentrated agunst flake polyethylene f^ycoL, re-dialysed against 2 mw-EDTA, fihered tturough a Mflhpore filter (pore 
size 0.22 #m) and stored at 4*C until used.
Protein solution (40 pi, 100 pg  of CFE/well and 10 pg of 
CE/well) was separated by SÛDS/PAGE on 2.5 mm x 80 
mm X 120 mm slab gels under reducing conditions as pre­
viously described (Ferro et ef_ 1988).
Geb were placed into about 500 ml ( 1:2, w/v) aquacide ID 
slurry (Behring Diaposiics) in distilled water, and left at 
room temperature untd the dimensions decreased from 2.5 mm X 80 nun x 120 aim to approximately 1 mm x SO
Abbreviaiions used; PACE, pofyacryiamide-gct ekctropboresii; 
CMP-PBS. calciuffl-magnesiuro-free phosphate-buffered sahne: 
CE, ce# extract: CFE. ceO-free extract.
116 kOt 
97 kO#
Fig. I. A comparison o f the band patterns o f CE (tracks 2-J. 7-8/ aitd CFE (tracks 4-5. 9 -lOi on (al a wet 10% (w/vi SDSIPAGE gel 
and (bl thi same gel apet aquacide reduction arid vacuum 
dehydration
mm X 90 mm (this represents a 16-fold decrease in gel 
volume). Rates of dehydration o f  the gels were related to the 
acrylamide concentrations. Geb with concentrations of 5. 
7.5 and 10% (w/v, took about 60. 90 and 120 min, respec­
tively, to reduce to the stated dimensions (with removal of 
90% of waierL The dehydrated geb were then rinsed in 
distilled water and placed on to filter paper (Whatman na 2) 
in a gel drier (Pharmacia) and covered with chng film. A hot- 
air blower was posmoned about 150 mm above the geb to ■d the drying process. The geb were left for a hinher 3b to 
dry completely and then placed under a 1 kg weight over­
night before being bbelled and stored permanently in poly­
thene bags.Identical geb took over 48 h to process to a thin film in 
the drier wWmut p iw  dehydration in aquacide and were 
susceptible to cracking Reducing the geb to these dimen­
sions meaiu that four geb can be dried down tamuhaneousl) compared with only one without prim aquacide dehydration.
An additional advant^ of thb procâhire, apart from the 
rapid processing time, b that weakly stained bands pre­
viously not visible can be dearly identified sfter aquacide 
dehydratioo. Thb b due to the foci that reduction in size 
resuhs in diffuse bands becoming concentrated and com­
pacted in a small area.For our particular application, the band ponems of both 
CE and CFTE initially appeared to be the same when run on a 
conventional 10% gel (Fig. la) even though in a dot-blot 
adhesion assay (Ferro ei a/,, 1988) CE promoted adhesion of 
the 816 melanoma cefls whereas CFE did not. On further 
treatment of the geb with aquacide. minor barxb became 
visible including a high-molecular-mass (above 200 kDa)
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component in CE but not in CFE (Fig 16), thus explaining the difference in adhesion properties of the two extracts.
It is possible to accurately assess molecular mass from the dried gels since the slurry of aquacide causes dehydration to 
cKcur evenly across the gel surface. Hence there is no distor­tion of the gels. Furthermore, aquacide dehydration prevents the gels from crackitqg during subsequent vacuum drying.
In our hands, the use of aquacide in pre-dehydration of gels has enabled us to idenmy and quantify by scanning 
densitometry, minor protein components associated with cell 
adhesion and to make more accurate molecular mass assess­ments of protein mixtures. The technique has also reduced 
the time involved in processing and has given us a space con­
serving permanent record of our data. We believe that the
technique will have many further uses including applications 
in autoradiography.
%  are grateful to the Association for International Cancer 
Research for ihetr suppon of this study.
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Press. Oxford
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APPENDIX 5 - EFFECT OF ANTIBODIES ON ADHESION TO FIBRONECTIN
The antibodies (at a dilution of 1:100 of the concentration shown in brackets) 
which inhibited adhesion to fibronectin were the monoclonals anti-FNl (250ug/ml) and 
anti“FN2 (1390ug/ml) and the polyclonals anti-FN (18mg/ml) and anti-BAE EXT 
(3.2mg/ml).
Anti-LM (at a dilution of Q.G01mg/ml)inhibited adhesion to laminin.
APPENDIX 6  - EFFECT OF ANTIBODIES ON SPREADING TO FIBRONECTIN 
AND LAMININ
Fibronectin
The following antibodies show a significant inhibition of cell spread to 40ug/ml 
Fn: anti-FN2 (0.14mg/ml), anti-BAE EXT (0.032mg/ml) and anti-FN (0.18mg/ml) - 
the F ratios are shown on the following graph. The table shows the response for the 
antibodies tested.
The effect of active antibodies inhibiting cell spread to Fn
antibody
%  no. of cells spread — SD 
neat 1:10 1 :1 0% 1:104
^-FNl 80.2 75.0 72.1 69.8 66.9
(250ug/ml) + 4.3 ± 4.1 i  6.1 + 2.5 ±2.5
^-FN2 33.3 40.6 66.1 80.7 80.6
(1.4mg/ml) ± 2.9 ± 3.1 ±5.2 ± 3.7 ± 5.1
^-BAE EXT 0.0 0.0 0.0 71.7 68.9
(3.2mg/ml) ± 0.0 ± 0.0 ±0.0 ± 0.35 ± 1,4
^-FN 0.0 0.0 0.0 74.5 70.4
(18mg/ml) ^ 0 . 0 i  0.0 ± 0.0 ± 3.1 ±2.5
%  Spread cells
100
80
60
40
20
0
neat 1:10 1:100 1:1000 1:10000
-Q- anti-Fn2 (f=ii9.8, (df:i,20))
anti-BAE Ext (f=i970.9, (df%i,2 0 )) 
anti-Fn (f=i650.5, (df:i,20))
A B  dilution
n-4
CONTROL
Laminin
A comparison was made of spreading on Lm in the presence and absence of 
antibodies which revealed that anti-LM (Img/ml) showed a significant inhibition of 
cell spread to 30ug/ml Lm. The F ratios are as shown on the following graph. The 
following table shows a summary of the response for the antibodies tested.
The effect of anti-LM in inhibiting cell spread to Lm 
n=4
% no. of spread cells — SD
antibody neat 1:10 1 : # 1 :1 0^ 1 :1 0 ^
^-LM (p) 3.1 6 6 . 2 69.2 70.6 71.0(Img/ml) ± 0.5 ^4 .1 ±3.4 ± 4.2 ±4.1
^-BAE EXT (p) 84.3 82.6 81.1 79.0 79.2(3.2mg/ml) ± 4.1 i  3.5 ±  3.1 + 4.5 ± 4.1
^-FN (p) 84.2 81.3 80.5 78.8 78.9(18mg/rnl) ± 3.4 ± 2.7 + 4.2 ± 3.9 ± 4 .1
The neat concentration of the antibody is shown in brackets.
% Spread cells
80
60
40
20
0
neat 1:10 1:100 1:1000 1:10000
A B  dilution
H3- anti-Lm (F=94.6, (df:l,20)) n-4
#  CO NTRO L
APPENDIX 7 - EFFECT OF ANTIBODIES ON MIGRATION TO FIBEQMECTIN 
ANDLAMININ
The method as described in Part 5.2.1 was used to produce a haptotaxis dose 
response curve with the test protein. The peak protein concentration obtained from the 
dose response curve was used to set up more chambers. Before incubating the chamber 
with cells, 500ul of 3% BSA was placed in the lower chamber and 200ul in the upper 
chamber for 30min at 37^C in order to block any adhesive sites on the filter. The BSA 
was aspirated and replaced with 500ul of diluted antibody in the lower chamber and 
200ul PBS in the upper chamber for Ihr at 37^C. The chambers were then washed 
twice with PBS before incubating with cells and staining as described in Part 5.2.1.
Fibronectin
The antibodies which showed a significant inhibition of cell migration to 
30ug/ml of Fn were the polyclonals anti-FN (18mg/ml) and anti-BAE EXT (3.2mg/ml) 
and the monoclonal anti-FN2 (1.39mg/ml). These were the same antibodies which 
inhibited spreading to Fn. The following table shows the response of these antibodies.
The effect of active antibodies in inhibiting migration to Fn.
'1
Cells moved/cm^ ± S.D.
antibody neat 1:10 1:100 1 : 1 0 0 0
^-FNl
(250ug/ml) 556.8±19.0
577.3 
± 12.5 577.3±23.2
575.0
±27.0
^-FN2
(1.4mg/ml) 0,0 ± 0.0
313.6±13.2 579.5±29.5
580.0 
± 28.0
^-BAE EXT 
(3.2mg/ml) 272.7± 1 2 . 6
370.5 ± 15.2 493.0±19.0
495.0 
± 14.5
a-FN
(18mg/ml) 0,0± 0.0
84.1 
± 6.5
420.0±19.0
431.8 
± 23.4
The following graph shows the effect of these antibodies in inhibiting migration
to Fn.
No of cells moved/cm
800
800
400
200
0
neat 1:10 1:100 1:1000 1:10000
AB dilution
n-3
g CONTROL.
-Q- antifn2 (f=227.9, (d f ji , i6 ) )  
anti-BAE Ext ( f = 1 7 6 . 6 ,  (d f: i,i6 ))  
anti-Fn {f=534.8, (d f ii , i6 ) )
Laminin
The antibodies which showed a significant inhibition of cell migration to 
40ug/ml of Lm were anti-LM (Img/ml) and anti-FN (18mg/ml). The following table 
summarise the responses. Anti-LM inhibits spreading and migration to Lm; anti-FN 
inhibits migration only.
The effect of active antibodies in the inhibition of migration to Lm. n-3
Cells moved/cm^ -  S.D.
antibody neat 1:10 1:100 1 : 1 0 0 0
^-Fn(18mg/ml) 0,0± 0.0 551.0 ± 2 2 . 0 598.7 ± 25.2 599.0 ± 23.6
^-Lm(Img/ml) 0,0± 0.0 2 0 . 8  ± 2.4 341.2± 12.1 399.0±16.8
The following graph shows the effect of these antibodies in the inhibition of 
migration to Lm.
No of cells moved/cm
600
500
400
300
200
100
T T TT
neat 1:10 1:100 1:1000 1:10000
A B  dilution
n-3
-43- anti-Fn (F=89.9, (df:l,16)) 
anti-Lm (F=1177.8, (df:l,16))
m  CONTROL
APPENDIX 8 - AGGREGATION PROMOTING PROPERTIES OF VARIOUS 
PROTEINS
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APPENDIX 9 - PROGRESSION OF CELL FRONTS
B16F10 cells and BAE cells were harvested as usual in EC medium with BAE 
supplements. Petri dishes were set up with a four-chambered silicon insert (Flexiperm, 
Heraeus) as shown in the photograph. In each dish B16F10 cells were seeded into two 
chambers at 0.64 x 10^ cells/ml and BAE cells into the other two chambers at 1.6 x 10^ 
cells/ml. The cells were allowed to grow for three days. The medium was aspirated 
and the rubber insert carefully removed. 5mls of medium was gently placed into the 
dish. The medium was changed every three days.
For microscopic observation of the progression of the cell fronts, a system was 
developed whereby a specific area on a dish could be located. A scratch mark on the 
side of the petri dish was matched up with a marking on the stage of the microscope. 
The vernier scale on the slide movement controls was then used to position and relocate 
chosen areas of each dish to provide information on the forward progression of cell 
fronts across the 3mm gap between the ceU types caused by the rubber insert. The 
progression of B16F10 cell fronts across the gap was measured and compared in the 
presence and absence of BAE cells. Similarly the progression of the BAE cell fronts 
across the gap was measured and compared in the presence and absence of B16F10 
cells. The following photograph shows the petri dish system used in this assay.

B16F10 cell front progression fuml
Total distance moved (um)
Time (hours) BAE cells absent BAE cells present
+ S.D. + S.D.
0 0 .0  + 0.0 0 .0  + 0.0
17 50.0 + 37.7 300.0 + 100.0
24 150.0 + 70.7 500 + 100.0
41 350.0 + 95.7 800 -t- 230.9
71 1700 + 355.9 2100.0 + 244.9
The following graph shows the B16F10 cell front progression in the presence and 
absence of BAE cells.
total distance moved/um
300 0  - ,
2000
1000
0 4020 6 0
-O" BAE absent 
BAE present
time/hours
n-3
(F=22.9, (df:1,20))
BAE cell front progression rum")
Total distance moved (um)
Time (hours) B16F10 cells absent B16F10 cells present
±S.D . ± S.D.
0 0 .0  + 0.0 0 .0  ±  0.0
17 1325.0 ±  275.0 350.0 ± 100.0
24 1700.0 ± 141.4 450.0 ± 41.4
41 2975.0 ± 200.0 750.0 ± 244.9
71 3975.0 ± 590.0 1875.0 ± 230.9
The following graph shows the BAE cell front progression in the presence and 
absence of B16F10 cells.
total distance moved/um
4000 n
3000 -
2000 -
1000 -
600 20 40 80
time/hours
n-3
-Q- B16 absent 
B16 present
( F= 21 1 .4 ,  ( d f : 1 , 2 0 ) )
In the presence of BAE cells, the B16F10 front across the gap increased 
significantly (compared with in the absence of BAE cells ). The F ratio is shown on 
the graphs. In the presence of B16F10 cells, the BAE front across the gap increased 
significantly (compared with in tge absence of B16F10 cells). It is not possible to 
determine whether the results obtained were due to changes in cell proliferation or 
migration. A study using time-lapse photography might prove invaluable in this case.
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